id	sid	tid	token	lemma	pos
cord-290319-decr6wrd	1	1	key	key	JJ
cord-290319-decr6wrd	2	1	:	:	:
cord-290319-decr6wrd	2	2	cord-290319-decr6wrd	cord-290319-decr6wrd	NN
cord-290319-decr6wrd	2	3	authors	author	NNS
cord-290319-decr6wrd	2	4	:	:	:
cord-290319-decr6wrd	2	5	Kayali	Kayali	NNP
cord-290319-decr6wrd	2	6	,	,	,
cord-290319-decr6wrd	2	7	Ghazi	Ghazi	NNP
cord-290319-decr6wrd	2	8	;	;	:
cord-290319-decr6wrd	2	9	Peiris	Peiris	NNP
cord-290319-decr6wrd	2	10	,	,	,
cord-290319-decr6wrd	2	11	Malik	Malik	NNP
cord-290319-decr6wrd	2	12	title	title	NN
cord-290319-decr6wrd	2	13	:	:	:
cord-290319-decr6wrd	3	1	A	a	DT
cord-290319-decr6wrd	3	2	more	more	RBR
cord-290319-decr6wrd	3	3	detailed	detailed	JJ
cord-290319-decr6wrd	3	4	picture	picture	NN
cord-290319-decr6wrd	3	5	of	of	IN
cord-290319-decr6wrd	3	6	the	the	DT
cord-290319-decr6wrd	3	7	epidemiology	epidemiology	NN
cord-290319-decr6wrd	3	8	of	of	IN
cord-290319-decr6wrd	3	9	Middle	Middle	NNP
cord-290319-decr6wrd	3	10	East	East	NNP
cord-290319-decr6wrd	3	11	respiratory	respiratory	JJ
cord-290319-decr6wrd	3	12	syndrome	syndrome	NN
cord-290319-decr6wrd	3	13	coronavirus	coronavirus	NN
cord-290319-decr6wrd	3	14	date	date	NN
cord-290319-decr6wrd	3	15	:	:	:
cord-290319-decr6wrd	3	16	2015	2015	CD
cord-290319-decr6wrd	3	17	-	-	HYPH
cord-290319-decr6wrd	3	18	05	05	CD
cord-290319-decr6wrd	3	19	-	-	HYPH
cord-290319-decr6wrd	3	20	31	31	CD
cord-290319-decr6wrd	3	21	journal	journal	NN
cord-290319-decr6wrd	3	22	:	:	:
cord-290319-decr6wrd	4	1	The	the	DT
cord-290319-decr6wrd	4	2	Lancet	Lancet	NNP
cord-290319-decr6wrd	4	3	Infectious	Infectious	NNP
cord-290319-decr6wrd	4	4	Diseases	Diseases	NNPS
cord-290319-decr6wrd	4	5	DOI	doi	NN
cord-290319-decr6wrd	4	6	:	:	:
cord-290319-decr6wrd	4	7	10.1016	10.1016	CD
cord-290319-decr6wrd	4	8	/	/	SYM
cord-290319-decr6wrd	4	9	s1473	s1473	NN
cord-290319-decr6wrd	4	10	-	-	HYPH
cord-290319-decr6wrd	4	11	3099(15)70128	3099(15)70128	NNP
cord-290319-decr6wrd	4	12	-	-	HYPH
cord-290319-decr6wrd	4	13	3	3	CD
cord-290319-decr6wrd	4	14	sha	sha	NN
cord-290319-decr6wrd	4	15	:	:	:
cord-290319-decr6wrd	4	16	db2e3cd37361d5ccb4c28e1052f739952bb32098	db2e3cd37361d5ccb4c28e1052f739952bb32098	NNP
cord-290319-decr6wrd	4	17	doc_id	doc_id	CD
cord-290319-decr6wrd	4	18	:	:	:
cord-290319-decr6wrd	4	19	290319	290319	CD
cord-290319-decr6wrd	4	20	cord_uid	cord_uid	NNS
cord-290319-decr6wrd	4	21	:	:	:
cord-290319-decr6wrd	5	1	decr6wrd	decr6wrd	RB
cord-290319-decr6wrd	5	2	nan	nan	NNP
cord-290319-decr6wrd	6	1	the	the	DT
cord-290319-decr6wrd	6	2	diff	diff	NNP
cord-290319-decr6wrd	6	3	erential	erential	NN
cord-290319-decr6wrd	6	4	diagnosis	diagnosis	NN
cord-290319-decr6wrd	6	5	of	of	IN
cord-290319-decr6wrd	6	6	sepsis	sepsis	NN
cord-290319-decr6wrd	6	7	or	or	CC
cord-290319-decr6wrd	6	8	meningitis	meningitis	NN
cord-290319-decr6wrd	6	9	is	be	VBZ
cord-290319-decr6wrd	6	10	broad	broad	JJ
cord-290319-decr6wrd	6	11	.	.	.
cord-290319-decr6wrd	7	1	Third	third	RB
cord-290319-decr6wrd	7	2	,	,	,
cord-290319-decr6wrd	7	3	although	although	IN
cord-290319-decr6wrd	7	4	the	the	DT
cord-290319-decr6wrd	7	5	path	path	NN
cord-290319-decr6wrd	7	6	to	to	IN
cord-290319-decr6wrd	7	7	commercialisation	commercialisation	NN
cord-290319-decr6wrd	7	8	is	be	VBZ
cord-290319-decr6wrd	7	9	underway	underway	JJ
cord-290319-decr6wrd	7	10	,	,	,
cord-290319-decr6wrd	7	11	it	-PRON-	PRP
cord-290319-decr6wrd	7	12	might	may	MD
cord-290319-decr6wrd	7	13	be	be	VB
cord-290319-decr6wrd	7	14	challenging	challenging	JJ
cord-290319-decr6wrd	7	15	.	.	.
cord-290319-decr6wrd	8	1	Inexpensive	inexpensive	JJ
cord-290319-decr6wrd	8	2	,	,	,
cord-290319-decr6wrd	8	3	straightforward	straightforward	JJ
cord-290319-decr6wrd	8	4	assays	assay	NNS
cord-290319-decr6wrd	8	5	are	be	VBP
cord-290319-decr6wrd	8	6	excellent	excellent	JJ
cord-290319-decr6wrd	8	7	from	from	IN
cord-290319-decr6wrd	8	8	public	public	JJ
cord-290319-decr6wrd	8	9	health	health	NN
cord-290319-decr6wrd	8	10	and	and	CC
cord-290319-decr6wrd	8	11	global	global	JJ
cord-290319-decr6wrd	8	12	health	health	NN
cord-290319-decr6wrd	8	13	perspectives	perspective	NNS
cord-290319-decr6wrd	8	14	,	,	,
cord-290319-decr6wrd	8	15	but	but	CC
cord-290319-decr6wrd	8	16	disruptive	disruptive	JJ
cord-290319-decr6wrd	8	17	new	new	JJ
cord-290319-decr6wrd	8	18	technologies	technology	NNS
cord-290319-decr6wrd	8	19	are	be	VBP
cord-290319-decr6wrd	8	20	not	not	RB
cord-290319-decr6wrd	8	21	always	always	RB
cord-290319-decr6wrd	8	22	adopted	adopt	VBN
cord-290319-decr6wrd	8	23	.	.	.
cord-290319-decr6wrd	9	1	Irrespective	irrespective	RB
cord-290319-decr6wrd	9	2	of	of	IN
cord-290319-decr6wrd	9	3	how	how	WRB
cord-290319-decr6wrd	9	4	successful	successful	JJ
cord-290319-decr6wrd	9	5	the	the	DT
cord-290319-decr6wrd	9	6	commercialisation	commercialisation	NN
cord-290319-decr6wrd	9	7	process	process	NN
cord-290319-decr6wrd	9	8	is	be	VBZ
cord-290319-decr6wrd	9	9	,	,	,
cord-290319-decr6wrd	9	10	the	the	DT
cord-290319-decr6wrd	9	11	authors	author	NNS
cord-290319-decr6wrd	9	12	have	have	VBP
cord-290319-decr6wrd	9	13	developed	develop	VBN
cord-290319-decr6wrd	9	14	a	a	DT
cord-290319-decr6wrd	9	15	novel	novel	JJ
cord-290319-decr6wrd	9	16	diagnostic	diagnostic	JJ
cord-290319-decr6wrd	9	17	test	test	NN
cord-290319-decr6wrd	9	18	for	for	IN
cord-290319-decr6wrd	9	19	Neisseria	Neisseria	NNP
cord-290319-decr6wrd	9	20	meningitidis	meningitidis	NNP
cord-290319-decr6wrd	9	21	that	that	WDT
cord-290319-decr6wrd	9	22	is	be	VBZ
cord-290319-decr6wrd	9	23	easy	easy	JJ
cord-290319-decr6wrd	9	24	to	to	TO
cord-290319-decr6wrd	9	25	use	use	VB
cord-290319-decr6wrd	9	26	and	and	CC
cord-290319-decr6wrd	9	27	provides	provide	VBZ
cord-290319-decr6wrd	9	28	results	result	NNS
cord-290319-decr6wrd	9	29	within	within	IN
cord-290319-decr6wrd	9	30	90	90	CD
cord-290319-decr6wrd	9	31	min	min	NN
cord-290319-decr6wrd	9	32	.	.	.
cord-290319-decr6wrd	10	1	In	in	IN
cord-290319-decr6wrd	10	2	such	such	PDT
cord-290319-decr6wrd	10	3	a	a	DT
cord-290319-decr6wrd	10	4	timeframe	timeframe	NN
cord-290319-decr6wrd	10	5	,	,	,
cord-290319-decr6wrd	10	6	results	result	NNS
cord-290319-decr6wrd	10	7	can	can	MD
cord-290319-decr6wrd	10	8	lead	lead	VB
cord-290319-decr6wrd	10	9	to	to	IN
cord-290319-decr6wrd	10	10	actionable	actionable	JJ
cord-290319-decr6wrd	10	11	decisionmaking	decisionmaking	NN
cord-290319-decr6wrd	10	12	,	,	,
cord-290319-decr6wrd	10	13	most	most	RBS
cord-290319-decr6wrd	10	14	likely	likely	JJ
cord-290319-decr6wrd	10	15	to	to	TO
cord-290319-decr6wrd	10	16	halt	halt	VB
cord-290319-decr6wrd	10	17	further	further	JJ
cord-290319-decr6wrd	10	18	diagnostic	diagnostic	JJ
cord-290319-decr6wrd	10	19	testing	testing	NN
cord-290319-decr6wrd	10	20	.	.	.
cord-290319-decr6wrd	11	1	The	the	DT
cord-290319-decr6wrd	11	2	niche	niche	NN
cord-290319-decr6wrd	11	3	for	for	IN
cord-290319-decr6wrd	11	4	LAMP	lamp	NN
cord-290319-decr6wrd	11	5	in	in	IN
cord-290319-decr6wrd	11	6	meningococcal	meningococcal	JJ
cord-290319-decr6wrd	11	7	disease	disease	NN
cord-290319-decr6wrd	11	8	remains	remain	VBZ
cord-290319-decr6wrd	11	9	to	to	TO
cord-290319-decr6wrd	11	10	be	be	VB
cord-290319-decr6wrd	11	11	established	establish	VBN
cord-290319-decr6wrd	11	12	,	,	,
cord-290319-decr6wrd	11	13	but	but	CC
cord-290319-decr6wrd	11	14	the	the	DT
cord-290319-decr6wrd	11	15	fact	fact	NN
cord-290319-decr6wrd	11	16	that	that	IN
cord-290319-decr6wrd	11	17	the	the	DT
cord-290319-decr6wrd	11	18	technique	technique	NN
cord-290319-decr6wrd	11	19	allows	allow	VBZ
cord-290319-decr6wrd	11	20	diagnostic	diagnostic	JJ
cord-290319-decr6wrd	11	21	confi	confi	NN
cord-290319-decr6wrd	11	22	rmation	rmation	NN
cord-290319-decr6wrd	11	23	at	at	IN
cord-290319-decr6wrd	11	24	the	the	DT
cord-290319-decr6wrd	11	25	treating	treat	VBG
cord-290319-decr6wrd	11	26	hospital	hospital	NN
cord-290319-decr6wrd	11	27	rather	rather	RB
cord-290319-decr6wrd	11	28	than	than	IN
cord-290319-decr6wrd	11	29	a	a	DT
cord-290319-decr6wrd	11	30	reference	reference	NN
cord-290319-decr6wrd	11	31	laboratory	laboratory	NN
cord-290319-decr6wrd	11	32	is	be	VBZ
cord-290319-decr6wrd	11	33	a	a	DT
cord-290319-decr6wrd	11	34	good	good	JJ
cord-290319-decr6wrd	11	35	start	start	NN
cord-290319-decr6wrd	11	36	.	.	.
cord-290319-decr6wrd	12	1	3	3	LS
cord-290319-decr6wrd	12	2	Most	Most	JJS
cord-290319-decr6wrd	12	3	cases	case	NNS
cord-290319-decr6wrd	12	4	were	be	VBD
cord-290319-decr6wrd	12	5	in	in	IN
cord-290319-decr6wrd	12	6	countries	country	NNS
cord-290319-decr6wrd	12	7	in	in	IN
cord-290319-decr6wrd	12	8	the	the	DT
cord-290319-decr6wrd	12	9	Arabian	Arabian	NNP
cord-290319-decr6wrd	12	10	Peninsula	Peninsula	NNP
cord-290319-decr6wrd	12	11	,	,	,
cord-290319-decr6wrd	12	12	with	with	IN
cord-290319-decr6wrd	12	13	sporadic	sporadic	JJ
cord-290319-decr6wrd	12	14	travel	travel	NN
cord-290319-decr6wrd	12	15	-	-	HYPH
cord-290319-decr6wrd	12	16	related	relate	VBN
cord-290319-decr6wrd	12	17	infections	infection	NNS
cord-290319-decr6wrd	12	18	occurring	occur	VBG
cord-290319-decr6wrd	12	19	elsewhere	elsewhere	RB
cord-290319-decr6wrd	12	20	.	.	.
cord-290319-decr6wrd	13	1	Although	although	IN
cord-290319-decr6wrd	13	2	clusters	cluster	NNS
cord-290319-decr6wrd	13	3	of	of	IN
cord-290319-decr6wrd	13	4	human	human	NN
cord-290319-decr6wrd	13	5	-	-	HYPH
cord-290319-decr6wrd	13	6	to	to	IN
cord-290319-decr6wrd	13	7	-	-	HYPH
cord-290319-decr6wrd	13	8	human	human	JJ
cord-290319-decr6wrd	13	9	transmission	transmission	NN
cord-290319-decr6wrd	13	10	of	of	IN
cord-290319-decr6wrd	13	11	MERS	MERS	NNP
cord-290319-decr6wrd	13	12	-	-	HYPH
cord-290319-decr6wrd	13	13	CoV	CoV	NNP
cord-290319-decr6wrd	13	14	are	be	VBP
cord-290319-decr6wrd	13	15	well	well	RB
cord-290319-decr6wrd	13	16	documented	document	VBN
cord-290319-decr6wrd	13	17	,	,	,
cord-290319-decr6wrd	13	18	transmission	transmission	NN
cord-290319-decr6wrd	13	19	originates	originate	VBZ
cord-290319-decr6wrd	13	20	from	from	IN
cord-290319-decr6wrd	13	21	zoonotic	zoonotic	JJ
cord-290319-decr6wrd	13	22	events	event	NNS
cord-290319-decr6wrd	13	23	,	,	,
cord-290319-decr6wrd	13	24	and	and	CC
cord-290319-decr6wrd	13	25	therefore	therefore	RB
cord-290319-decr6wrd	13	26	identifi	identifi	NNP
cord-290319-decr6wrd	13	27	cation	cation	NNP
cord-290319-decr6wrd	13	28	of	of	IN
cord-290319-decr6wrd	13	29	the	the	DT
cord-290319-decr6wrd	13	30	animal	animal	NN
cord-290319-decr6wrd	13	31	sources	source	NNS
cord-290319-decr6wrd	13	32	of	of	IN
cord-290319-decr6wrd	13	33	MERS	MERS	NNP
cord-290319-decr6wrd	13	34	-	-	HYPH
cord-290319-decr6wrd	13	35	CoV	CoV	NNP
cord-290319-decr6wrd	13	36	is	be	VBZ
cord-290319-decr6wrd	13	37	a	a	DT
cord-290319-decr6wrd	13	38	priority	priority	NN
cord-290319-decr6wrd	13	39	.	.	.
cord-290319-decr6wrd	14	1	Genetically	genetically	RB
cord-290319-decr6wrd	14	2	,	,	,
cord-290319-decr6wrd	14	3	MERS	MERS	NNP
cord-290319-decr6wrd	14	4	-	-	HYPH
cord-290319-decr6wrd	14	5	CoV	CoV	NNP
cord-290319-decr6wrd	14	6	is	be	VBZ
cord-290319-decr6wrd	14	7	related	relate	VBN
cord-290319-decr6wrd	14	8	to	to	IN
cord-290319-decr6wrd	14	9	bat	bat	NN
cord-290319-decr6wrd	14	10	coronaviruses	coronaviruse	NNS
cord-290319-decr6wrd	14	11	from	from	IN
cord-290319-decr6wrd	14	12	China	China	NNP
cord-290319-decr6wrd	14	13	,	,	,
cord-290319-decr6wrd	14	14	Saudi	Saudi	NNP
cord-290319-decr6wrd	14	15	Arabia	Arabia	NNP
cord-290319-decr6wrd	14	16	,	,	,
cord-290319-decr6wrd	14	17	Europe	Europe	NNP
cord-290319-decr6wrd	14	18	,	,	,
cord-290319-decr6wrd	14	19	and	and	CC
cord-290319-decr6wrd	14	20	Africa	Africa	NNP
cord-290319-decr6wrd	14	21	.	.	.
cord-290319-decr6wrd	15	1	2,4	2,4	CD
cord-290319-decr6wrd	15	2	-	-	SYM
cord-290319-decr6wrd	15	3	6	6	CD
cord-290319-decr6wrd	16	1	On	on	IN
cord-290319-decr6wrd	16	2	the	the	DT
cord-290319-decr6wrd	16	3	basis	basis	NN
cord-290319-decr6wrd	16	4	of	of	IN
cord-290319-decr6wrd	16	5	the	the	DT
cord-290319-decr6wrd	16	6	evidence	evidence	NN
cord-290319-decr6wrd	16	7	so	so	RB
cord-290319-decr6wrd	16	8	far	far	RB
cord-290319-decr6wrd	16	9	,	,	,
cord-290319-decr6wrd	16	10	none	none	NN
cord-290319-decr6wrd	16	11	of	of	IN
cord-290319-decr6wrd	16	12	the	the	DT
cord-290319-decr6wrd	16	13	bats	bat	NNS
cord-290319-decr6wrd	16	14	from	from	IN
cord-290319-decr6wrd	16	15	these	these	DT
cord-290319-decr6wrd	16	16	countries	country	NNS
cord-290319-decr6wrd	16	17	are	be	VBP
cord-290319-decr6wrd	16	18	likely	likely	JJ
cord-290319-decr6wrd	16	19	to	to	TO
cord-290319-decr6wrd	16	20	be	be	VB
cord-290319-decr6wrd	16	21	the	the	DT
cord-290319-decr6wrd	16	22	reservoir	reservoir	NN
cord-290319-decr6wrd	16	23	for	for	IN
cord-290319-decr6wrd	16	24	the	the	DT
cord-290319-decr6wrd	16	25	virus	virus	NN
cord-290319-decr6wrd	16	26	.	.	.
cord-290319-decr6wrd	17	1	Evidence	evidence	NN
cord-290319-decr6wrd	17	2	is	be	VBZ
cord-290319-decr6wrd	17	3	accumulating	accumulate	VBG
cord-290319-decr6wrd	17	4	that	that	IN
cord-290319-decr6wrd	17	5	dromedary	dromedary	NN
cord-290319-decr6wrd	17	6	camels	camel	NNS
cord-290319-decr6wrd	17	7	are	be	VBP
cord-290319-decr6wrd	17	8	a	a	DT
cord-290319-decr6wrd	17	9	natural	natural	JJ
cord-290319-decr6wrd	17	10	host	host	NN
cord-290319-decr6wrd	17	11	of	of	IN
cord-290319-decr6wrd	17	12	MERS	MERS	NNP
cord-290319-decr6wrd	18	1	-CoV.	-CoV.	:
cord-290319-decr6wrd	18	2	Serological	Serological	NNP
cord-290319-decr6wrd	18	3	fi	fi	NN
cord-290319-decr6wrd	18	4	ndings	nding	NNS
cord-290319-decr6wrd	18	5	suggest	suggest	VBP
cord-290319-decr6wrd	18	6	that	that	IN
cord-290319-decr6wrd	18	7	more	more	JJR
cord-290319-decr6wrd	18	8	than	than	IN
cord-290319-decr6wrd	18	9	90	90	CD
cord-290319-decr6wrd	18	10	%	%	NN
cord-290319-decr6wrd	18	11	of	of	IN
cord-290319-decr6wrd	18	12	adult	adult	NN
cord-290319-decr6wrd	18	13	dromedaries	dromedary	NNS
cord-290319-decr6wrd	18	14	in	in	IN
cord-290319-decr6wrd	18	15	the	the	DT
cord-290319-decr6wrd	18	16	Middle	Middle	NNP
cord-290319-decr6wrd	18	17	East	East	NNP
cord-290319-decr6wrd	18	18	and	and	CC
cord-290319-decr6wrd	18	19	Africa	Africa	NNP
cord-290319-decr6wrd	18	20	are	be	VBP
cord-290319-decr6wrd	18	21	seropositive	seropositive	JJ
cord-290319-decr6wrd	18	22	for	for	IN
cord-290319-decr6wrd	18	23	MERS	MERS	NNP
cord-290319-decr6wrd	18	24	-	-	HYPH
cord-290319-decr6wrd	18	25	CoV.	CoV.	NNP
cord-290319-decr6wrd	18	26	7	7	CD
cord-290319-decr6wrd	19	1	The	the	DT
cord-290319-decr6wrd	19	2	virus	virus	NN
cord-290319-decr6wrd	19	3	isolated	isolate	VBN
cord-290319-decr6wrd	19	4	from	from	IN
cord-290319-decr6wrd	19	5	dromedaries	dromedary	NNS
cord-290319-decr6wrd	19	6	has	have	VBZ
cord-290319-decr6wrd	19	7	spike	spike	NN
cord-290319-decr6wrd	19	8	proteins	protein	NNS
cord-290319-decr6wrd	19	9	with	with	IN
cord-290319-decr6wrd	19	10	conserved	conserved	JJ
cord-290319-decr6wrd	19	11	receptor	receptor	NN
cord-290319-decr6wrd	19	12	-	-	HYPH
cord-290319-decr6wrd	19	13	binding	bind	VBG
cord-290319-decr6wrd	19	14	domains	domain	NNS
cord-290319-decr6wrd	19	15	for	for	IN
cord-290319-decr6wrd	19	16	the	the	DT
cord-290319-decr6wrd	19	17	human	human	JJ
cord-290319-decr6wrd	19	18	dipeptidyl	dipeptidyl	NNP
cord-290319-decr6wrd	19	19	peptidase-4	peptidase-4	NNP
cord-290319-decr6wrd	19	20	receptor	receptor	NN
cord-290319-decr6wrd	19	21	,	,	,
cord-290319-decr6wrd	19	22	8	8	CD
cord-290319-decr6wrd	19	23	,	,	,
cord-290319-decr6wrd	19	24	9	9	CD
cord-290319-decr6wrd	19	25	and	and	CC
cord-290319-decr6wrd	19	26	MERS	MERS	NNP
cord-290319-decr6wrd	19	27	-	-	HYPH
cord-290319-decr6wrd	19	28	CoV	CoV	NNP
cord-290319-decr6wrd	19	29	has	have	VBZ
cord-290319-decr6wrd	19	30	been	be	VBN
cord-290319-decr6wrd	19	31	detected	detect	VBN
cord-290319-decr6wrd	19	32	in	in	IN
cord-290319-decr6wrd	19	33	camels	camel	NNS
cord-290319-decr6wrd	19	34	that	that	WDT
cord-290319-decr6wrd	19	35	were	be	VBD
cord-290319-decr6wrd	19	36	in	in	IN
cord-290319-decr6wrd	19	37	close	close	JJ
cord-290319-decr6wrd	19	38	contact	contact	NN
cord-290319-decr6wrd	19	39	with	with	IN
cord-290319-decr6wrd	19	40	people	people	NNS
cord-290319-decr6wrd	19	41	with	with	IN
cord-290319-decr6wrd	19	42	Middle	Middle	NNP
cord-290319-decr6wrd	19	43	East	East	NNP
cord-290319-decr6wrd	19	44	respiratory	respiratory	JJ
cord-290319-decr6wrd	19	45	syndrome	syndrome	NN
cord-290319-decr6wrd	19	46	.	.	.
cord-290319-decr6wrd	20	1	10	10	CD
cord-290319-decr6wrd	20	2	,	,	,
cord-290319-decr6wrd	20	3	11	11	CD
cord-290319-decr6wrd	21	1	The	the	DT
cord-290319-decr6wrd	21	2	role	role	NN
cord-290319-decr6wrd	21	3	of	of	IN
cord-290319-decr6wrd	21	4	camels	camel	NNS
cord-290319-decr6wrd	21	5	as	as	IN
cord-290319-decr6wrd	21	6	a	a	DT
cord-290319-decr6wrd	21	7	source	source	NN
cord-290319-decr6wrd	21	8	of	of	IN
cord-290319-decr6wrd	21	9	human	human	JJ
cord-290319-decr6wrd	21	10	infection	infection	NN
cord-290319-decr6wrd	21	11	with	with	IN
cord-290319-decr6wrd	21	12	Middle	Middle	NNP
cord-290319-decr6wrd	21	13	East	East	NNP
cord-290319-decr6wrd	21	14	respiratory	respiratory	JJ
cord-290319-decr6wrd	21	15	syndrome	syndrome	NN
cord-290319-decr6wrd	21	16	is	be	VBZ
cord-290319-decr6wrd	21	17	controversial	controversial	JJ
cord-290319-decr6wrd	21	18	because	because	IN
cord-290319-decr6wrd	21	19	many	many	JJ
cord-290319-decr6wrd	21	20	people	people	NNS
cord-290319-decr6wrd	21	21	who	who	WP
cord-290319-decr6wrd	21	22	have	have	VBP
cord-290319-decr6wrd	21	23	the	the	DT
cord-290319-decr6wrd	21	24	disease	disease	NN
cord-290319-decr6wrd	21	25	have	have	VB
cord-290319-decr6wrd	21	26	had	have	VBN
cord-290319-decr6wrd	21	27	no	no	DT
cord-290319-decr6wrd	21	28	obvious	obvious	JJ
cord-290319-decr6wrd	21	29	association	association	NN
cord-290319-decr6wrd	21	30	with	with	IN
cord-290319-decr6wrd	21	31	camels	camel	NNS
cord-290319-decr6wrd	21	32	.	.	.
cord-290319-decr6wrd	22	1	Case	case	NN
cord-290319-decr6wrd	22	2	-	-	HYPH
cord-290319-decr6wrd	22	3	control	control	NN
cord-290319-decr6wrd	22	4	studies	study	NNS
cord-290319-decr6wrd	22	5	that	that	WDT
cord-290319-decr6wrd	22	6	aim	aim	VBP
cord-290319-decr6wrd	22	7	to	to	TO
cord-290319-decr6wrd	22	8	defi	defi	NNP
cord-290319-decr6wrd	22	9	ne	ne	NNP
cord-290319-decr6wrd	22	10	risk	risk	NN
cord-290319-decr6wrd	22	11	exposures	exposure	NNS
cord-290319-decr6wrd	22	12	of	of	IN
cord-290319-decr6wrd	22	13	index	index	NN
cord-290319-decr6wrd	22	14	patients	patient	NNS
cord-290319-decr6wrd	22	15	have	have	VBP
cord-290319-decr6wrd	22	16	not	not	RB
cord-290319-decr6wrd	22	17	yet	yet	RB
cord-290319-decr6wrd	22	18	been	be	VBN
cord-290319-decr6wrd	22	19	done	do	VBN
cord-290319-decr6wrd	22	20	,	,	,
cord-290319-decr6wrd	22	21	and	and	CC
cord-290319-decr6wrd	22	22	an	an	DT
cord-290319-decr6wrd	22	23	investigation	investigation	NN
cord-290319-decr6wrd	22	24	of	of	IN
cord-290319-decr6wrd	22	25	MERS	MERS	NNP
cord-290319-decr6wrd	22	26	-	-	HYPH
cord-290319-decr6wrd	22	27	CoV	cov	NN
cord-290319-decr6wrd	22	28	seroprevalence	seroprevalence	NN
cord-290319-decr6wrd	22	29	in	in	IN
cord-290319-decr6wrd	22	30	people	people	NNS
cord-290319-decr6wrd	22	31	in	in	IN
cord-290319-decr6wrd	22	32	contact	contact	NN
cord-290319-decr6wrd	22	33	with	with	IN
cord-290319-decr6wrd	22	34	camels	camel	NNS
cord-290319-decr6wrd	22	35	yielded	yield	VBD
cord-290319-decr6wrd	22	36	negative	negative	JJ
cord-290319-decr6wrd	22	37	results	result	NNS
cord-290319-decr6wrd	22	38	(	(	-LRB-
cord-290319-decr6wrd	22	39	ie	ie	FW
cord-290319-decr6wrd	22	40	,	,	,
cord-290319-decr6wrd	22	41	no	no	DT
cord-290319-decr6wrd	22	42	association	association	NN
cord-290319-decr6wrd	22	43	was	be	VBD
cord-290319-decr6wrd	22	44	noted	note	VBN
cord-290319-decr6wrd	22	45	)	)	-RRB-
cord-290319-decr6wrd	22	46	.	.	.
cord-290319-decr6wrd	23	1	8	8	CD
cord-290319-decr6wrd	23	2	,	,	,
cord-290319-decr6wrd	23	3	[	[	-LRB-
cord-290319-decr6wrd	23	4	12	12	CD
cord-290319-decr6wrd	23	5	]	]	-RRB-
cord-290319-decr6wrd	23	6	[	[	-LRB-
cord-290319-decr6wrd	23	7	13	13	CD
cord-290319-decr6wrd	23	8	]	]	-RRB-
cord-290319-decr6wrd	24	1	[	[	-LRB-
cord-290319-decr6wrd	24	2	14	14	CD
cord-290319-decr6wrd	24	3	]	]	-RRB-
cord-290319-decr6wrd	25	1	The	the	DT
cord-290319-decr6wrd	25	2	study	study	NN
cord-290319-decr6wrd	25	3	by	by	IN
cord-290319-decr6wrd	25	4	Muller	Muller	NNP
cord-290319-decr6wrd	25	5	and	and	CC
cord-290319-decr6wrd	25	6	colleagues	colleague	NNS
cord-290319-decr6wrd	25	7	is	be	VBZ
cord-290319-decr6wrd	25	8	the	the	DT
cord-290319-decr6wrd	25	9	fi	fi	NNP
cord-290319-decr6wrd	25	10	rst	rst	NNP
cord-290319-decr6wrd	25	11	population	population	NN
cord-290319-decr6wrd	25	12	-	-	HYPH
cord-290319-decr6wrd	25	13	based	base	VBN
cord-290319-decr6wrd	25	14	,	,	,
cord-290319-decr6wrd	25	15	seroepidemiological	seroepidemiological	JJ
cord-290319-decr6wrd	25	16	investigation	investigation	NN
cord-290319-decr6wrd	25	17	of	of	IN
cord-290319-decr6wrd	25	18	MERS	MERS	NNP
cord-290319-decr6wrd	25	19	-	-	HYPH
cord-290319-decr6wrd	25	20	CoV	CoV	NNP
cord-290319-decr6wrd	25	21	infection	infection	NN
cord-290319-decr6wrd	25	22	in	in	IN
cord-290319-decr6wrd	25	23	an	an	DT
cord-290319-decr6wrd	25	24	area	area	NN
cord-290319-decr6wrd	25	25	where	where	WRB
cord-290319-decr6wrd	25	26	zoonotic	zoonotic	JJ
cord-290319-decr6wrd	25	27	transmission	transmission	NN
cord-290319-decr6wrd	25	28	is	be	VBZ
cord-290319-decr6wrd	25	29	sustained	sustain	VBN
cord-290319-decr6wrd	25	30	.	.	.
cord-290319-decr6wrd	26	1	The	the	DT
cord-290319-decr6wrd	26	2	investigators	investigator	NNS
cord-290319-decr6wrd	26	3	used	use	VBD
cord-290319-decr6wrd	26	4	a	a	DT
cord-290319-decr6wrd	26	5	cross	cross	JJ
cord-290319-decr6wrd	26	6	-	-	JJ
cord-290319-decr6wrd	26	7	sectional	sectional	JJ
cord-290319-decr6wrd	26	8	design	design	NN
cord-290319-decr6wrd	26	9	that	that	WDT
cord-290319-decr6wrd	26	10	tested	test	VBD
cord-290319-decr6wrd	26	11	serum	serum	NN
cord-290319-decr6wrd	26	12	samples	sample	NNS
cord-290319-decr6wrd	26	13	from	from	IN
cord-290319-decr6wrd	26	14	about	about	RB
cord-290319-decr6wrd	26	15	10	10	CD
cord-290319-decr6wrd	26	16	000	000	CD
cord-290319-decr6wrd	26	17	people	people	NNS
cord-290319-decr6wrd	26	18	in	in	IN
cord-290319-decr6wrd	26	19	Saudi	Saudi	NNP
cord-290319-decr6wrd	26	20	Arabia	Arabia	NNP
cord-290319-decr6wrd	26	21	whose	whose	WP$
cord-290319-decr6wrd	26	22	age	age	NN
cord-290319-decr6wrd	26	23	and	and	CC
cord-290319-decr6wrd	26	24	sex	sex	NN
cord-290319-decr6wrd	26	25	distribution	distribution	NN
cord-290319-decr6wrd	26	26	was	be	VBD
cord-290319-decr6wrd	26	27	similar	similar	JJ
cord-290319-decr6wrd	26	28	to	to	IN
cord-290319-decr6wrd	26	29	that	that	DT
cord-290319-decr6wrd	26	30	of	of	IN
cord-290319-decr6wrd	26	31	the	the	DT
cord-290319-decr6wrd	26	32	general	general	JJ
cord-290319-decr6wrd	26	33	population	population	NN
cord-290319-decr6wrd	26	34	.	.	.
cord-290319-decr6wrd	27	1	By	by	IN
cord-290319-decr6wrd	27	2	use	use	NN
cord-290319-decr6wrd	27	3	of	of	IN
cord-290319-decr6wrd	27	4	a	a	DT
cord-290319-decr6wrd	27	5	rigorous	rigorous	JJ
cord-290319-decr6wrd	27	6	serological	serological	JJ
cord-290319-decr6wrd	27	7	testing	testing	NN
cord-290319-decr6wrd	27	8	algorithm	algorithm	NN
cord-290319-decr6wrd	27	9	,	,	,
cord-290319-decr6wrd	27	10	the	the	DT
cord-290319-decr6wrd	27	11	investigators	investigator	NNS
cord-290319-decr6wrd	27	12	identifi	identifi	NNP
cord-290319-decr6wrd	27	13	ed	ed	NNP
cord-290319-decr6wrd	27	14	MERS	MERS	NNP
cord-290319-decr6wrd	27	15	-	-	HYPH
cord-290319-decr6wrd	27	16	CoV	CoV	NNP
cord-290319-decr6wrd	27	17	antibodies	antibody	NNS
cord-290319-decr6wrd	27	18	in	in	IN
cord-290319-decr6wrd	27	19	15	15	CD
cord-290319-decr6wrd	27	20	(	(	-LRB-
cord-290319-decr6wrd	27	21	0·15	0·15	CD
cord-290319-decr6wrd	27	22	%	%	NN
cord-290319-decr6wrd	27	23	,	,	,
cord-290319-decr6wrd	27	24	95	95	CD
cord-290319-decr6wrd	27	25	%	%	NN
cord-290319-decr6wrd	27	26	CI	CI	NNP
cord-290319-decr6wrd	27	27	0·09	0·09	CD
cord-290319-decr6wrd	27	28	-	-	HYPH
cord-290319-decr6wrd	27	29	0·24	0·24	CD
cord-290319-decr6wrd	27	30	)	)	-RRB-
cord-290319-decr6wrd	27	31	of	of	IN
cord-290319-decr6wrd	27	32	10	10	CD
cord-290319-decr6wrd	27	33	009	009	CD
cord-290319-decr6wrd	27	34	samples	sample	NNS
cord-290319-decr6wrd	27	35	from	from	IN
cord-290319-decr6wrd	27	36	the	the	DT
cord-290319-decr6wrd	27	37	general	general	JJ
cord-290319-decr6wrd	27	38	population	population	NN
cord-290319-decr6wrd	27	39	.	.	.
cord-290319-decr6wrd	28	1	Men	man	NNS
cord-290319-decr6wrd	28	2	had	have	VBD
cord-290319-decr6wrd	28	3	a	a	DT
cord-290319-decr6wrd	28	4	signifi	signifi	NNP
cord-290319-decr6wrd	28	5	cantly	cantly	RB
cord-290319-decr6wrd	28	6	higher	high	JJR
cord-290319-decr6wrd	28	7	proportion	proportion	NN
cord-290319-decr6wrd	28	8	of	of	IN
cord-290319-decr6wrd	28	9	infections	infection	NNS
cord-290319-decr6wrd	28	10	(	(	-LRB-
cord-290319-decr6wrd	28	11	11	11	CD
cord-290319-decr6wrd	28	12	[	[	-LRB-
cord-290319-decr6wrd	28	13	0·25	0·25	CD
cord-290319-decr6wrd	28	14	%	%	NN
cord-290319-decr6wrd	28	15	]	]	-RRB-
cord-290319-decr6wrd	28	16	of	of	IN
cord-290319-decr6wrd	28	17	4341	4341	CD
cord-290319-decr6wrd	28	18	)	)	-RRB-
cord-290319-decr6wrd	28	19	than	than	IN
cord-290319-decr6wrd	28	20	did	do	VBD
cord-290319-decr6wrd	28	21	women	woman	NNS
cord-290319-decr6wrd	28	22	(	(	-LRB-
cord-290319-decr6wrd	28	23	two	two	CD
cord-290319-decr6wrd	28	24	[	[	-LRB-
cord-290319-decr6wrd	28	25	0·05	0·05	CD
cord-290319-decr6wrd	28	26	%	%	NN
cord-290319-decr6wrd	28	27	]	]	-RRB-
cord-290319-decr6wrd	28	28	of	of	IN
cord-290319-decr6wrd	28	29	4378	4378	CD
cord-290319-decr6wrd	28	30	;	;	:
cord-290319-decr6wrd	28	31	p=0·025	p=0·025	NNP
cord-290319-decr6wrd	28	32	)	)	-RRB-
cord-290319-decr6wrd	28	33	,	,	,
cord-290319-decr6wrd	28	34	and	and	CC
cord-290319-decr6wrd	28	35	more	more	JJR
cord-290319-decr6wrd	28	36	infections	infection	NNS
cord-290319-decr6wrd	28	37	were	be	VBD
cord-290319-decr6wrd	28	38	noted	note	VBN
cord-290319-decr6wrd	28	39	in	in	IN
cord-290319-decr6wrd	28	40	central	central	JJ
cord-290319-decr6wrd	28	41	rural	rural	JJ
cord-290319-decr6wrd	28	42	areas	area	NNS
cord-290319-decr6wrd	28	43	than	than	IN
cord-290319-decr6wrd	28	44	in	in	IN
cord-290319-decr6wrd	28	45	coastal	coastal	JJ
cord-290319-decr6wrd	28	46	provinces	province	NNS
cord-290319-decr6wrd	28	47	(	(	-LRB-
cord-290319-decr6wrd	28	48	14	14	CD
cord-290319-decr6wrd	28	49	[	[	-LRB-
cord-290319-decr6wrd	28	50	0·26	0·26	CD
cord-290319-decr6wrd	28	51	%	%	NN
cord-290319-decr6wrd	28	52	]	]	-RRB-
cord-290319-decr6wrd	28	53	of	of	IN
cord-290319-decr6wrd	28	54	5479	5479	CD
cord-290319-decr6wrd	28	55	vs	vs	IN
cord-290319-decr6wrd	28	56	one	one	CD
cord-290319-decr6wrd	28	57	[	[	-LRB-
cord-290319-decr6wrd	28	58	0·02	0·02	CD
cord-290319-decr6wrd	28	59	%	%	NN
cord-290319-decr6wrd	28	60	]	]	-RRB-
cord-290319-decr6wrd	28	61	of	of	IN
cord-290319-decr6wrd	28	62	4529	4529	CD
cord-290319-decr6wrd	28	63	;	;	:
cord-290319-decr6wrd	28	64	p=0·003	p=0·003	NNP
cord-290319-decr6wrd	28	65	)	)	-RRB-
cord-290319-decr6wrd	28	66	.	.	.
cord-290319-decr6wrd	29	1	The	the	DT
cord-290319-decr6wrd	29	2	investigators	investigator	NNS
cord-290319-decr6wrd	29	3	also	also	RB
cord-290319-decr6wrd	29	4	obtained	obtain	VBD
cord-290319-decr6wrd	29	5	samples	sample	NNS
cord-290319-decr6wrd	29	6	from	from	IN
cord-290319-decr6wrd	29	7	camel	camel	NN
cord-290319-decr6wrd	29	8	shepherds	shepherd	NNS
cord-290319-decr6wrd	29	9	and	and	CC
cord-290319-decr6wrd	29	10	slaughterhouse	slaughterhouse	NN
cord-290319-decr6wrd	29	11	workers	worker	NNS
cord-290319-decr6wrd	29	12	,	,	,
cord-290319-decr6wrd	29	13	and	and	CC
cord-290319-decr6wrd	29	14	showed	show	VBD
cord-290319-decr6wrd	29	15	that	that	IN
cord-290319-decr6wrd	29	16	seroprevalence	seroprevalence	NN
cord-290319-decr6wrd	29	17	of	of	IN
cord-290319-decr6wrd	29	18	MERS	MERS	NNP
cord-290319-decr6wrd	29	19	-	-	HYPH
cord-290319-decr6wrd	29	20	CoV	CoV	NNP
cord-290319-decr6wrd	29	21	was	be	VBD
cord-290319-decr6wrd	29	22	15	15	CD
cord-290319-decr6wrd	29	23	-	-	SYM
cord-290319-decr6wrd	29	24	23	23	CD
cord-290319-decr6wrd	29	25	times	time	NNS
cord-290319-decr6wrd	29	26	higher	high	JJR
cord-290319-decr6wrd	29	27	in	in	IN
cord-290319-decr6wrd	29	28	camel	camel	NN
cord-290319-decr6wrd	29	29	-	-	HYPH
cord-290319-decr6wrd	29	30	exposed	expose	VBN
cord-290319-decr6wrd	29	31	individuals	individual	NNS
cord-290319-decr6wrd	29	32	than	than	IN
cord-290319-decr6wrd	29	33	in	in	IN
cord-290319-decr6wrd	29	34	the	the	DT
cord-290319-decr6wrd	29	35	general	general	JJ
cord-290319-decr6wrd	29	36	population	population	NN
cord-290319-decr6wrd	29	37	.	.	.
cord-290319-decr6wrd	30	1	The	the	DT
cord-290319-decr6wrd	30	2	fi	fi	NN
cord-290319-decr6wrd	30	3	ndings	nding	NNS
cord-290319-decr6wrd	30	4	from	from	IN
cord-290319-decr6wrd	30	5	this	this	DT
cord-290319-decr6wrd	30	6	study	study	NN
cord-290319-decr6wrd	30	7	suggest	suggest	VBP
cord-290319-decr6wrd	30	8	that	that	IN
cord-290319-decr6wrd	30	9	young	young	JJ
cord-290319-decr6wrd	30	10	men	man	NNS
cord-290319-decr6wrd	30	11	in	in	IN
cord-290319-decr6wrd	30	12	Saudi	Saudi	NNP
cord-290319-decr6wrd	30	13	Arabia	Arabia	NNP
cord-290319-decr6wrd	30	14	who	who	WP
cord-290319-decr6wrd	30	15	have	have	VBP
cord-290319-decr6wrd	30	16	contact	contact	NN
cord-290319-decr6wrd	30	17	with	with	IN
cord-290319-decr6wrd	30	18	camels	camel	NNS
cord-290319-decr6wrd	30	19	in	in	IN
cord-290319-decr6wrd	30	20	cultural	cultural	JJ
cord-290319-decr6wrd	30	21	or	or	CC
cord-290319-decr6wrd	30	22	occupational	occupational	JJ
cord-290319-decr6wrd	30	23	settings	setting	NNS
cord-290319-decr6wrd	30	24	are	be	VBP
cord-290319-decr6wrd	30	25	becoming	become	VBG
cord-290319-decr6wrd	30	26	infected	infect	VBN
cord-290319-decr6wrd	30	27	with	with	IN
cord-290319-decr6wrd	30	28	MERS	MERS	NNP
cord-290319-decr6wrd	30	29	-	-	HYPH
cord-290319-decr6wrd	30	30	CoV	CoV	NNP
cord-290319-decr6wrd	30	31	,	,	,
cord-290319-decr6wrd	30	32	often	often	RB
cord-290319-decr6wrd	30	33	without	without	IN
cord-290319-decr6wrd	30	34	being	be	VBG
cord-290319-decr6wrd	30	35	diagnosed	diagnose	VBN
cord-290319-decr6wrd	30	36	,	,	,
cord-290319-decr6wrd	30	37	and	and	CC
cord-290319-decr6wrd	30	38	might	may	MD
cord-290319-decr6wrd	30	39	proceed	proceed	VB
cord-290319-decr6wrd	30	40	to	to	TO
cord-290319-decr6wrd	30	41	introduce	introduce	VB
cord-290319-decr6wrd	30	42	the	the	DT
cord-290319-decr6wrd	30	43	virus	virus	NN
cord-290319-decr6wrd	30	44	to	to	IN
cord-290319-decr6wrd	30	45	the	the	DT
cord-290319-decr6wrd	30	46	general	general	JJ
cord-290319-decr6wrd	30	47	population	population	NN
cord-290319-decr6wrd	30	48	in	in	IN
cord-290319-decr6wrd	30	49	which	which	WDT
cord-290319-decr6wrd	30	50	more	more	RBR
cord-290319-decr6wrd	30	51	severe	severe	JJ
cord-290319-decr6wrd	30	52	illness	illness	NN
cord-290319-decr6wrd	30	53	triggers	trigger	VBZ
cord-290319-decr6wrd	30	54	testing	test	VBG
cord-290319-decr6wrd	30	55	for	for	IN
cord-290319-decr6wrd	30	56	the	the	DT
cord-290319-decr6wrd	30	57	virus	virus	NN
cord-290319-decr6wrd	30	58	and	and	CC
cord-290319-decr6wrd	30	59	disease	disease	NN
cord-290319-decr6wrd	30	60	recognition	recognition	NN
cord-290319-decr6wrd	30	61	.	.	.
cord-290319-decr6wrd	31	1	This	this	DT
cord-290319-decr6wrd	31	2	hypothesis	hypothesis	NN
cord-290319-decr6wrd	31	3	could	could	MD
cord-290319-decr6wrd	31	4	account	account	VB
cord-290319-decr6wrd	31	5	for	for	IN
cord-290319-decr6wrd	31	6	cases	case	NNS
cord-290319-decr6wrd	31	7	of	of	IN
cord-290319-decr6wrd	31	8	Middle	Middle	NNP
cord-290319-decr6wrd	31	9	East	East	NNP
cord-290319-decr6wrd	31	10	respiratory	respiratory	JJ
cord-290319-decr6wrd	31	11	syndrome	syndrome	NN
cord-290319-decr6wrd	31	12	without	without	IN
cord-290319-decr6wrd	31	13	previous	previous	JJ
cord-290319-decr6wrd	31	14	animal	animal	NN
cord-290319-decr6wrd	31	15	exposure	exposure	NN
cord-290319-decr6wrd	31	16	.	.	.
cord-290319-decr6wrd	32	1	When	when	WRB
cord-290319-decr6wrd	32	2	the	the	DT
cord-290319-decr6wrd	32	3	data	datum	NNS
cord-290319-decr6wrd	32	4	from	from	IN
cord-290319-decr6wrd	32	5	Muller	Muller	NNP
cord-290319-decr6wrd	32	6	and	and	CC
cord-290319-decr6wrd	32	7	colleagues	colleague	NNS
cord-290319-decr6wrd	32	8	1	1	CD
cord-290319-decr6wrd	32	9	are	be	VBP
cord-290319-decr6wrd	32	10	put	put	VBN
cord-290319-decr6wrd	32	11	into	into	IN
cord-290319-decr6wrd	32	12	context	context	NN
cord-290319-decr6wrd	32	13	with	with	IN
cord-290319-decr6wrd	32	14	those	those	DT
cord-290319-decr6wrd	32	15	from	from	IN
cord-290319-decr6wrd	32	16	studies	study	NNS
cord-290319-decr6wrd	32	17	in	in	IN
cord-290319-decr6wrd	32	18	camels	camel	NNS
cord-290319-decr6wrd	32	19	,	,	,
cord-290319-decr6wrd	32	20	a	a	DT
cord-290319-decr6wrd	32	21	clearer	clear	JJR
cord-290319-decr6wrd	32	22	picture	picture	NN
cord-290319-decr6wrd	32	23	of	of	IN
cord-290319-decr6wrd	32	24	the	the	DT
cord-290319-decr6wrd	32	25	epidemiology	epidemiology	NN
cord-290319-decr6wrd	32	26	of	of	IN
cord-290319-decr6wrd	32	27	MERS	MERS	NNP
cord-290319-decr6wrd	32	28	-	-	HYPH
cord-290319-decr6wrd	32	29	CoV	CoV	NNP
cord-290319-decr6wrd	32	30	emerges	emerge	VBZ
cord-290319-decr6wrd	32	31	(	(	-LRB-
cord-290319-decr6wrd	32	32	fi	fi	FW
cord-290319-decr6wrd	32	33	gure	gure	NNP
cord-290319-decr6wrd	32	34	)	)	-RRB-
cord-290319-decr6wrd	32	35	.	.	.
cord-290319-decr6wrd	33	1	Camels	camel	NNS
cord-290319-decr6wrd	33	2	seem	seem	VBP
cord-290319-decr6wrd	33	3	to	to	TO
cord-290319-decr6wrd	33	4	be	be	VB
cord-290319-decr6wrd	33	5	a	a	DT
cord-290319-decr6wrd	33	6	natural	natural	JJ
cord-290319-decr6wrd	33	7	host	host	NN
cord-290319-decr6wrd	33	8	for	for	IN
cord-290319-decr6wrd	33	9	MERS	MERS	NNP
cord-290319-decr6wrd	33	10	-	-	HYPH
cord-290319-decr6wrd	33	11	CoV	CoV	NNP
cord-290319-decr6wrd	33	12	and	and	CC
cord-290319-decr6wrd	33	13	transmission	transmission	NN
cord-290319-decr6wrd	33	14	within	within	IN
cord-290319-decr6wrd	33	15	camel	camel	NN
cord-290319-decr6wrd	33	16	herds	herd	NNS
cord-290319-decr6wrd	33	17	is	be	VBZ
cord-290319-decr6wrd	33	18	well	well	RB
cord-290319-decr6wrd	33	19	established	establish	VBN
cord-290319-decr6wrd	33	20	.	.	.
cord-290319-decr6wrd	34	1	15	15	CD
cord-290319-decr6wrd	35	1	However	however	RB
cord-290319-decr6wrd	35	2	,	,	,
cord-290319-decr6wrd	35	3	several	several	JJ
cord-290319-decr6wrd	35	4	questions	question	NNS
cord-290319-decr6wrd	35	5	need	need	VBP
cord-290319-decr6wrd	35	6	to	to	TO
cord-290319-decr6wrd	35	7	be	be	VB
cord-290319-decr6wrd	35	8	resolved	resolve	VBN
cord-290319-decr6wrd	35	9	.	.	.
cord-290319-decr6wrd	36	1	The	the	DT
cord-290319-decr6wrd	36	2	route	route	NN
cord-290319-decr6wrd	36	3	for	for	IN
cord-290319-decr6wrd	36	4	camel	camel	NN
cord-290319-decr6wrd	36	5	-	-	HYPH
cord-290319-decr6wrd	36	6	to	to	IN
cord-290319-decr6wrd	36	7	-	-	HYPH
cord-290319-decr6wrd	36	8	human	human	JJ
cord-290319-decr6wrd	36	9	transmission	transmission	NN
cord-290319-decr6wrd	36	10	is	be	VBZ
cord-290319-decr6wrd	36	11	unclear	unclear	JJ
cord-290319-decr6wrd	36	12	,	,	,
cord-290319-decr6wrd	36	13	and	and	CC
cord-290319-decr6wrd	36	14	could	could	MD
cord-290319-decr6wrd	36	15	be	be	VB
cord-290319-decr6wrd	36	16	from	from	IN
cord-290319-decr6wrd	36	17	one	one	CD
cord-290319-decr6wrd	36	18	or	or	CC
cord-290319-decr6wrd	36	19	more	more	JJR
cord-290319-decr6wrd	36	20	of	of	IN
cord-290319-decr6wrd	36	21	the	the	DT
cord-290319-decr6wrd	36	22	following	following	NN
cord-290319-decr6wrd	36	23	:	:	:
cord-290319-decr6wrd	36	24	direct	direct	JJ
cord-290319-decr6wrd	36	25	contact	contact	NN
cord-290319-decr6wrd	36	26	with	with	IN
cord-290319-decr6wrd	36	27	infected	infected	JJ
cord-290319-decr6wrd	36	28	animals	animal	NNS
cord-290319-decr6wrd	36	29	,	,	,
cord-290319-decr6wrd	36	30	or	or	CC
cord-290319-decr6wrd	36	31	consumption	consumption	NN
cord-290319-decr6wrd	36	32	of	of	IN
cord-290319-decr6wrd	36	33	milk	milk	NN
cord-290319-decr6wrd	36	34	,	,	,
cord-290319-decr6wrd	36	35	urine	urine	NN
cord-290319-decr6wrd	36	36	,	,	,
cord-290319-decr6wrd	36	37	or	or	CC
cord-290319-decr6wrd	36	38	uncooked	uncooked	JJ
cord-290319-decr6wrd	36	39	meat	meat	NN
cord-290319-decr6wrd	36	40	-	-	:
cord-290319-decr6wrd	36	41	all	all	DT
cord-290319-decr6wrd	36	42	practices	practice	NNS
cord-290319-decr6wrd	36	43	that	that	WDT
cord-290319-decr6wrd	36	44	are	be	VBP
cord-290319-decr6wrd	36	45	common	common	JJ
cord-290319-decr6wrd	36	46	in	in	IN
cord-290319-decr6wrd	36	47	aff	aff	NNP
cord-290319-decr6wrd	36	48	ected	ected	JJ
cord-290319-decr6wrd	36	49	countries	country	NNS
cord-290319-decr6wrd	36	50	in	in	IN
cord-290319-decr6wrd	36	51	the	the	DT
cord-290319-decr6wrd	36	52	Middle	Middle	NNP
cord-290319-decr6wrd	36	53	East	East	NNP
cord-290319-decr6wrd	36	54	.	.	.
cord-290319-decr6wrd	37	1	An	an	DT
cord-290319-decr6wrd	37	2	intermediate	intermediate	JJ
cord-290319-decr6wrd	37	3	host	host	NN
cord-290319-decr6wrd	37	4	could	could	MD
cord-290319-decr6wrd	37	5	also	also	RB
cord-290319-decr6wrd	37	6	transmit	transmit	VB
cord-290319-decr6wrd	37	7	MERS	MERS	NNP
cord-290319-decr6wrd	37	8	-	-	HYPH
cord-290319-decr6wrd	37	9	CoV	CoV	NNP
cord-290319-decr6wrd	37	10	between	between	IN
cord-290319-decr6wrd	37	11	camels	camel	NNS
cord-290319-decr6wrd	37	12	and	and	CC
cord-290319-decr6wrd	37	13	human	human	JJ
cord-290319-decr6wrd	37	14	beings	being	NNS
cord-290319-decr6wrd	37	15	.	.	.
cord-290319-decr6wrd	38	1	Finally	finally	RB
cord-290319-decr6wrd	38	2	,	,	,
cord-290319-decr6wrd	38	3	whether	whether	IN
cord-290319-decr6wrd	38	4	dromedaries	dromedary	NNS
cord-290319-decr6wrd	38	5	are	be	VBP
cord-290319-decr6wrd	38	6	the	the	DT
cord-290319-decr6wrd	38	7	natural	natural	JJ
cord-290319-decr6wrd	38	8	reservoir	reservoir	NN
cord-290319-decr6wrd	38	9	or	or	CC
cord-290319-decr6wrd	38	10	an	an	DT
cord-290319-decr6wrd	38	11	amplifi	amplifi	XX
cord-290319-decr6wrd	39	1	er	er	UH
cord-290319-decr6wrd	39	2	host	host	NN
cord-290319-decr6wrd	39	3	is	be	VBZ
cord-290319-decr6wrd	39	4	a	a	DT
cord-290319-decr6wrd	39	5	hypothesis	hypothesis	NN
cord-290319-decr6wrd	39	6	that	that	WDT
cord-290319-decr6wrd	39	7	is	be	VBZ
cord-290319-decr6wrd	39	8	open	open	JJ
cord-290319-decr6wrd	39	9	to	to	IN
cord-290319-decr6wrd	39	10	further	further	JJ
cord-290319-decr6wrd	39	11	investigation	investigation	NN
cord-290319-decr6wrd	39	12	.	.	.
cord-290319-decr6wrd	40	1	Muller	Muller	NNP
cord-290319-decr6wrd	40	2	and	and	CC
cord-290319-decr6wrd	40	3	colleagues	colleague	NNS
cord-290319-decr6wrd	40	4	'	'	POS
cord-290319-decr6wrd	40	5	study	study	NN
cord-290319-decr6wrd	40	6	is	be	VBZ
cord-290319-decr6wrd	40	7	the	the	DT
cord-290319-decr6wrd	40	8	fi	fi	NN
cord-290319-decr6wrd	40	9	rst	rst	NN
cord-290319-decr6wrd	40	10	step	step	NN
cord-290319-decr6wrd	40	11	along	along	IN
cord-290319-decr6wrd	40	12	the	the	DT
cord-290319-decr6wrd	40	13	way	way	NN
cord-290319-decr6wrd	40	14	to	to	IN
cord-290319-decr6wrd	40	15	addressing	address	VBG
cord-290319-decr6wrd	40	16	these	these	DT
cord-290319-decr6wrd	40	17	questions	question	NNS
cord-290319-decr6wrd	40	18	.	.	.
cord-290319-decr6wrd	40	19	 	 	_SP
cord-290319-decr6wrd	41	1	Human	human	JJ
cord-290319-decr6wrd	41	2	papillomavirus	papillomavirus	NN
cord-290319-decr6wrd	41	3	(	(	-LRB-
cord-290319-decr6wrd	41	4	HPV	HPV	NNP
cord-290319-decr6wrd	41	5	)	)	-RRB-
cord-290319-decr6wrd	41	6	vaccination	vaccination	NN
cord-290319-decr6wrd	41	7	programmes	programme	NNS
cord-290319-decr6wrd	41	8	have	have	VBP
cord-290319-decr6wrd	41	9	been	be	VBN
cord-290319-decr6wrd	41	10	in	in	IN
cord-290319-decr6wrd	41	11	use	use	NN
cord-290319-decr6wrd	41	12	in	in	IN
cord-290319-decr6wrd	41	13	many	many	JJ
cord-290319-decr6wrd	41	14	countries	country	NNS
cord-290319-decr6wrd	41	15	since	since	IN
cord-290319-decr6wrd	41	16	2007	2007	CD
cord-290319-decr6wrd	41	17	following	following	NN
cord-290319-decr6wrd	41	18	licensing	licensing	NN
cord-290319-decr6wrd	41	19	of	of	IN
cord-290319-decr6wrd	41	20	the	the	DT
cord-290319-decr6wrd	41	21	bivalent	bivalent	NN
cord-290319-decr6wrd	41	22	and	and	CC
cord-290319-decr6wrd	41	23	quadrivalent	quadrivalent	JJ
cord-290319-decr6wrd	41	24	HPV	HPV	NNP
cord-290319-decr6wrd	41	25	vaccines	vaccine	NNS
cord-290319-decr6wrd	41	26	.	.	.
cord-290319-decr6wrd	42	1	1	1	LS
cord-290319-decr6wrd	42	2	Clinical	clinical	JJ
cord-290319-decr6wrd	42	3	trials	trial	NNS
cord-290319-decr6wrd	42	4	have	have	VBP
cord-290319-decr6wrd	42	5	shown	show	VBN
cord-290319-decr6wrd	42	6	that	that	IN
cord-290319-decr6wrd	42	7	HPV	HPV	NNP
cord-290319-decr6wrd	42	8	vaccines	vaccine	NNS
cord-290319-decr6wrd	42	9	have	have	VBP
cord-290319-decr6wrd	42	10	more	more	JJR
cord-290319-decr6wrd	42	11	than	than	IN
cord-290319-decr6wrd	42	12	90	90	CD
cord-290319-decr6wrd	42	13	%	%	NN
cord-290319-decr6wrd	42	14	effi	effi	NNP
cord-290319-decr6wrd	42	15	cacy	cacy	NN
cord-290319-decr6wrd	42	16	in	in	IN
cord-290319-decr6wrd	42	17	preventing	prevent	VBG
cord-290319-decr6wrd	42	18	high	high	JJ
cord-290319-decr6wrd	42	19	-	-	HYPH
cord-290319-decr6wrd	42	20	grade	grade	NN
cord-290319-decr6wrd	42	21	cervical	cervical	JJ
cord-290319-decr6wrd	42	22	lesions	lesion	NNS
cord-290319-decr6wrd	42	23	caused	cause	VBN
cord-290319-decr6wrd	42	24	by	by	IN
cord-290319-decr6wrd	42	25	human	human	JJ
cord-290319-decr6wrd	42	26	papillomavirus	papillomavirus	NN
cord-290319-decr6wrd	42	27	types	type	NNS
cord-290319-decr6wrd	42	28	16	16	CD
cord-290319-decr6wrd	42	29	and	and	CC
cord-290319-decr6wrd	42	30	18	18	CD
cord-290319-decr6wrd	42	31	,	,	,
cord-290319-decr6wrd	42	32	2,3	2,3	CD
cord-290319-decr6wrd	42	33	which	which	WDT
cord-290319-decr6wrd	42	34	are	be	VBP
cord-290319-decr6wrd	42	35	the	the	DT
cord-290319-decr6wrd	42	36	two	two	CD
cord-290319-decr6wrd	42	37	HPV	hpv	NN
cord-290319-decr6wrd	42	38	types	type	NNS
cord-290319-decr6wrd	42	39	known	know	VBN
cord-290319-decr6wrd	42	40	to	to	TO
cord-290319-decr6wrd	42	41	cause	cause	VB
cord-290319-decr6wrd	42	42	70	70	CD
cord-290319-decr6wrd	42	43	-	-	SYM
cord-290319-decr6wrd	42	44	80	80	CD
cord-290319-decr6wrd	42	45	%	%	NN
cord-290319-decr6wrd	42	46	of	of	IN
cord-290319-decr6wrd	42	47	cervical	cervical	JJ
cord-290319-decr6wrd	42	48	cancers	cancer	NNS
cord-290319-decr6wrd	42	49	and	and	CC
cord-290319-decr6wrd	42	50	large	large	JJ
cord-290319-decr6wrd	42	51	proportions	proportion	NNS
cord-290319-decr6wrd	42	52	of	of	IN
cord-290319-decr6wrd	42	53	other	other	JJ
cord-290319-decr6wrd	42	54	anogenital	anogenital	NNS
cord-290319-decr6wrd	42	55	and	and	CC
cord-290319-decr6wrd	42	56	oropharyngeal	oropharyngeal	JJ
cord-290319-decr6wrd	42	57	cancers	cancer	NNS
cord-290319-decr6wrd	42	58	.	.	.
cord-290319-decr6wrd	43	1	The	the	DT
cord-290319-decr6wrd	43	2	quadrivalent	quadrivalent	NN
cord-290319-decr6wrd	43	3	vaccine	vaccine	NN
cord-290319-decr6wrd	43	4	has	have	VBZ
cord-290319-decr6wrd	43	5	shown	show	VBN
cord-290319-decr6wrd	43	6	similar	similar	JJ
cord-290319-decr6wrd	43	7	effi	effi	NNP
cord-290319-decr6wrd	43	8	cacy	cacy	NN
cord-290319-decr6wrd	43	9	in	in	IN
cord-290319-decr6wrd	43	10	the	the	DT
cord-290319-decr6wrd	43	11	prevention	prevention	NN
cord-290319-decr6wrd	43	12	of	of	IN
cord-290319-decr6wrd	43	13	anogenital	anogenital	JJ
cord-290319-decr6wrd	43	14	warts	wart	NNS
cord-290319-decr6wrd	43	15	caused	cause	VBN
cord-290319-decr6wrd	43	16	by	by	IN
cord-290319-decr6wrd	43	17	HPV	hpv	NN
cord-290319-decr6wrd	43	18	types	type	NNS
cord-290319-decr6wrd	43	19	6	6	CD
cord-290319-decr6wrd	43	20	and	and	CC
cord-290319-decr6wrd	43	21	11	11	CD
cord-290319-decr6wrd	43	22	.	.	.
cord-290319-decr6wrd	44	1	Furthermore	furthermore	RB
cord-290319-decr6wrd	44	2	,	,	,
cord-290319-decr6wrd	44	3	both	both	DT
cord-290319-decr6wrd	44	4	vaccines	vaccine	NNS
cord-290319-decr6wrd	44	5	have	have	VBP
cord-290319-decr6wrd	44	6	shown	show	VBN
cord-290319-decr6wrd	44	7	lower	low	JJR
cord-290319-decr6wrd	44	8	-	-	:
cord-290319-decr6wrd	44	9	but	but	CC
cord-290319-decr6wrd	44	10	still	still	RB
cord-290319-decr6wrd	44	11	substantial	substantial	JJ
cord-290319-decr6wrd	44	12	-	-	HYPH
cord-290319-decr6wrd	44	13	effi	effi	JJ
cord-290319-decr6wrd	44	14	cacy	cacy	NN
cord-290319-decr6wrd	44	15	against	against	IN
cord-290319-decr6wrd	44	16	related	related	JJ
cord-290319-decr6wrd	44	17	non	non	JJ
cord-290319-decr6wrd	44	18	-	-	JJ
cord-290319-decr6wrd	44	19	vaccine	vaccine	JJ
cord-290319-decr6wrd	44	20	oncogenic	oncogenic	JJ
cord-290319-decr6wrd	44	21	human	human	JJ
cord-290319-decr6wrd	44	22	papillomavirus	papillomavirus	NN
cord-290319-decr6wrd	44	23	types	type	NNS
cord-290319-decr6wrd	44	24	.	.	.
cord-290319-decr6wrd	45	1	4,5	4,5	LS
cord-290319-decr6wrd	46	1	Therefore	therefore	RB
cord-290319-decr6wrd	46	2	,	,	,
cord-290319-decr6wrd	46	3	since	since	IN
cord-290319-decr6wrd	46	4	rollout	rollout	NN
cord-290319-decr6wrd	46	5	of	of	IN
cord-290319-decr6wrd	46	6	these	these	DT
cord-290319-decr6wrd	46	7	vaccination	vaccination	NN
cord-290319-decr6wrd	46	8	programmes	programme	NNS
cord-290319-decr6wrd	46	9	began	begin	VBD
cord-290319-decr6wrd	46	10	,	,	,
cord-290319-decr6wrd	46	11	there	there	EX
cord-290319-decr6wrd	46	12	has	have	VBZ
cord-290319-decr6wrd	46	13	been	be	VBN
cord-290319-decr6wrd	46	14	great	great	JJ
cord-290319-decr6wrd	46	15	anticipation	anticipation	NN
cord-290319-decr6wrd	46	16	to	to	TO
cord-290319-decr6wrd	46	17	see	see	VB
cord-290319-decr6wrd	46	18	whether	whether	IN
cord-290319-decr6wrd	46	19	these	these	DT
cord-290319-decr6wrd	46	20	promising	promising	JJ
cord-290319-decr6wrd	46	21	trial	trial	NN
cord-290319-decr6wrd	46	22	results	result	NNS
cord-290319-decr6wrd	46	23	will	will	MD
cord-290319-decr6wrd	46	24	translate	translate	VB
cord-290319-decr6wrd	46	25	into	into	IN
cord-290319-decr6wrd	46	26	substantial	substantial	JJ
cord-290319-decr6wrd	46	27	reductions	reduction	NNS
cord-290319-decr6wrd	46	28	in	in	IN
cord-290319-decr6wrd	46	29	HPV	hpv	NN
cord-290319-decr6wrd	46	30	-	-	HYPH
cord-290319-decr6wrd	46	31	related	relate	VBN
cord-290319-decr6wrd	46	32	disease	disease	NN
cord-290319-decr6wrd	46	33	at	at	IN
cord-290319-decr6wrd	46	34	the	the	DT
cord-290319-decr6wrd	46	35	population	population	NN
cord-290319-decr6wrd	46	36	level	level	NN
cord-290319-decr6wrd	46	37	.	.	.
cord-290319-decr6wrd	47	1	6	6	CD
cord-290319-decr6wrd	48	1	In	in	IN
cord-290319-decr6wrd	48	2	The	the	DT
cord-290319-decr6wrd	48	3	Lancet	Lancet	NNP
cord-290319-decr6wrd	48	4	Infectious	Infectious	NNP
cord-290319-decr6wrd	48	5	Diseases	Diseases	NNPS
cord-290319-decr6wrd	48	6	,	,	,
cord-290319-decr6wrd	48	7	Mélanie	Mélanie	NNP
cord-290319-decr6wrd	48	8	Drolet	Drolet	NNP
cord-290319-decr6wrd	48	9	and	and	CC
cord-290319-decr6wrd	48	10	colleagues	colleague	NNS
cord-290319-decr6wrd	48	11	present	present	VBP
cord-290319-decr6wrd	48	12	the	the	DT
cord-290319-decr6wrd	48	13	fi	fi	NNP
cord-290319-decr6wrd	48	14	ndings	nding	NNS
cord-290319-decr6wrd	48	15	of	of	IN
cord-290319-decr6wrd	48	16	a	a	DT
cord-290319-decr6wrd	48	17	timely	timely	RB
cord-290319-decr6wrd	48	18	systematic	systematic	JJ
cord-290319-decr6wrd	48	19	review	review	NN
cord-290319-decr6wrd	48	20	and	and	CC
cord-290319-decr6wrd	48	21	metaanalysis	metaanalysis	NN
cord-290319-decr6wrd	48	22	assessing	assess	VBG
cord-290319-decr6wrd	48	23	the	the	DT
cord-290319-decr6wrd	48	24	population	population	NN
cord-290319-decr6wrd	48	25	-	-	HYPH
cord-290319-decr6wrd	48	26	level	level	NN
cord-290319-decr6wrd	48	27	and	and	CC
cord-290319-decr6wrd	48	28	herd	herd	NN
cord-290319-decr6wrd	48	29	eff	eff	NNP
cord-290319-decr6wrd	48	30	ects	ect	NNS
cord-290319-decr6wrd	48	31	of	of	IN
cord-290319-decr6wrd	48	32	HPV	HPV	NNP
cord-290319-decr6wrd	48	33	vaccination	vaccination	NN
cord-290319-decr6wrd	48	34	programmes	programme	NNS
cord-290319-decr6wrd	48	35	so	so	RB
cord-290319-decr6wrd	48	36	far	far	RB
cord-290319-decr6wrd	48	37	.	.	.
cord-290319-decr6wrd	49	1	7	7	CD
cord-290319-decr6wrd	50	1	The	the	DT
cord-290319-decr6wrd	50	2	key	key	JJ
cord-290319-decr6wrd	50	3	fi	fi	NN
cord-290319-decr6wrd	50	4	ndings	nding	NNS
cord-290319-decr6wrd	50	5	of	of	IN
cord-290319-decr6wrd	50	6	the	the	DT
cord-290319-decr6wrd	50	7	study	study	NN
cord-290319-decr6wrd	50	8	suggest	suggest	VBP
cord-290319-decr6wrd	50	9	that	that	IN
cord-290319-decr6wrd	50	10	in	in	IN
cord-290319-decr6wrd	50	11	the	the	DT
cord-290319-decr6wrd	50	12	preto	preto	NNP
cord-290319-decr6wrd	50	13	-	-	HYPH
cord-290319-decr6wrd	50	14	post	post	JJ
cord-290319-decr6wrd	50	15	-	-	JJ
cord-290319-decr6wrd	50	16	vaccination	vaccination	JJ
cord-290319-decr6wrd	50	17	period	period	NN
cord-290319-decr6wrd	50	18	covered	cover	VBN
cord-290319-decr6wrd	50	19	by	by	IN
cord-290319-decr6wrd	50	20	the	the	DT
cord-290319-decr6wrd	50	21	19	19	CD
cord-290319-decr6wrd	50	22	included	include	VBN
cord-290319-decr6wrd	50	23	studies	study	NNS
cord-290319-decr6wrd	50	24	,	,	,
cord-290319-decr6wrd	50	25	HPV	HPV	NNP
cord-290319-decr6wrd	50	26	type	type	NN
cord-290319-decr6wrd	50	27	16	16	CD
cord-290319-decr6wrd	50	28	and	and	CC
cord-290319-decr6wrd	50	29	18	18	CD
cord-290319-decr6wrd	50	30	infections	infection	NNS
cord-290319-decr6wrd	50	31	and	and	CC
cord-290319-decr6wrd	50	32	anogenital	anogenital	JJ
cord-290319-decr6wrd	50	33	warts	wart	NNS
cord-290319-decr6wrd	50	34	have	have	VBP
cord-290319-decr6wrd	50	35	decreased	decrease	VBN
cord-290319-decr6wrd	50	36	by	by	IN
cord-290319-decr6wrd	50	37	more	more	JJR
cord-290319-decr6wrd	50	38	than	than	IN
cord-290319-decr6wrd	50	39	60	60	CD
cord-290319-decr6wrd	50	40	%	%	NN
cord-290319-decr6wrd	50	41	in	in	IN
cord-290319-decr6wrd	50	42	girls	girl	NNS
cord-290319-decr6wrd	50	43	(	(	-LRB-
cord-290319-decr6wrd	50	44	<	<	XX
cord-290319-decr6wrd	50	45	20	20	CD
cord-290319-decr6wrd	50	46	years	year	NNS
cord-290319-decr6wrd	50	47	of	of	IN
cord-290319-decr6wrd	50	48	age	age	NN
cord-290319-decr6wrd	50	49	)	)	-RRB-
cord-290319-decr6wrd	50	50	when	when	WRB
cord-290319-decr6wrd	50	51	high	high	JJ
cord-290319-decr6wrd	50	52	female	female	JJ
cord-290319-decr6wrd	50	53	vaccination	vaccination	NN
cord-290319-decr6wrd	50	54	coverage	coverage	NN
cord-290319-decr6wrd	50	55	(	(	-LRB-
cord-290319-decr6wrd	50	56	>	>	NFP
cord-290319-decr6wrd	50	57	50	50	CD
cord-290319-decr6wrd	50	58	%	%	NN
cord-290319-decr6wrd	50	59	)	)	-RRB-
cord-290319-decr6wrd	50	60	was	be	VBD
cord-290319-decr6wrd	50	61	reported	report	VBN
cord-290319-decr6wrd	50	62	.	.	.
cord-290319-decr6wrd	51	1	The	the	DT
cord-290319-decr6wrd	51	2	authors	author	NNS
cord-290319-decr6wrd	51	3	also	also	RB
cord-290319-decr6wrd	51	4	report	report	VBP
cord-290319-decr6wrd	51	5	signifi	signifi	NNP
cord-290319-decr6wrd	51	6	ca	can	MD
cord-290319-decr6wrd	51	7	nt	not	RB
cord-290319-decr6wrd	51	8	reductions	reduction	NNS
cord-290319-decr6wrd	51	9	in	in	IN
cord-290319-decr6wrd	51	10	HPV	HPV	NNP
cord-290319-decr6wrd	51	11	types	type	NNS
cord-290319-decr6wrd	51	12	31	31	CD
cord-290319-decr6wrd	51	13	,	,	,
cord-290319-decr6wrd	51	14	33	33	CD
cord-290319-decr6wrd	51	15	,	,	,
cord-290319-decr6wrd	51	16	and	and	CC
cord-290319-decr6wrd	51	17	45	45	CD
cord-290319-decr6wrd	51	18	infections	infection	NNS
cord-290319-decr6wrd	51	19	in	in	IN
cord-290319-decr6wrd	51	20	this	this	DT
cord-290319-decr6wrd	51	21	same	same	JJ
cord-290319-decr6wrd	51	22	group	group	NN
cord-290319-decr6wrd	51	23	(	(	-LRB-
cord-290319-decr6wrd	51	24	relative	relative	JJ
cord-290319-decr6wrd	51	25	risk	risk	NN
cord-290319-decr6wrd	51	26	[	[	-LRB-
cord-290319-decr6wrd	51	27	RR	rr	NN
cord-290319-decr6wrd	51	28	]	]	-RRB-
cord-290319-decr6wrd	51	29	0·72	0·72	CD
cord-290319-decr6wrd	51	30	[	[	-LRB-
cord-290319-decr6wrd	51	31	95	95	CD
cord-290319-decr6wrd	51	32	%	%	NN
cord-290319-decr6wrd	51	33	CI	CI	NNP
cord-290319-decr6wrd	51	34	0·54	0·54	CD
cord-290319-decr6wrd	51	35	-	-	HYPH
cord-290319-decr6wrd	51	36	0·96	0·96	CD
cord-290319-decr6wrd	51	37	]	]	-RRB-
cord-290319-decr6wrd	51	38	)	)	-RRB-
cord-290319-decr6wrd	51	39	and	and	CC
cord-290319-decr6wrd	51	40	in	in	IN
cord-290319-decr6wrd	51	41	anogenital	anogenital	JJ
cord-290319-decr6wrd	51	42	warts	wart	NNS
cord-290319-decr6wrd	51	43	in	in	IN
cord-290319-decr6wrd	51	44	boys	boy	NNS
cord-290319-decr6wrd	51	45	younger	young	JJR
cord-290319-decr6wrd	51	46	than	than	IN
cord-290319-decr6wrd	51	47	20	20	CD
cord-290319-decr6wrd	51	48	years	year	NNS
cord-290319-decr6wrd	51	49	of	of	IN
cord-290319-decr6wrd	51	50	age	age	NN
cord-290319-decr6wrd	51	51	(	(	-LRB-
cord-290319-decr6wrd	51	52	0·66	0·66	CD
cord-290319-decr6wrd	51	53	[	[	-LRB-
cord-290319-decr6wrd	51	54	0·47	0·47	CD
cord-290319-decr6wrd	51	55	-	-	HYPH
cord-290319-decr6wrd	51	56	0·91	0·91	CD
cord-290319-decr6wrd	51	57	]	]	-RRB-
cord-290319-decr6wrd	51	58	)	)	-RRB-
cord-290319-decr6wrd	51	59	and	and	CC
cord-290319-decr6wrd	51	60	in	in	IN
cord-290319-decr6wrd	51	61	women	woman	NNS
cord-290319-decr6wrd	51	62	20	20	CD
cord-290319-decr6wrd	51	63	-	-	SYM
cord-290319-decr6wrd	51	64	39	39	CD
cord-290319-decr6wrd	51	65	years	year	NNS
cord-290319-decr6wrd	51	66	of	of	IN
cord-290319-decr6wrd	51	67	age	age	NN
cord-290319-decr6wrd	51	68	(	(	-LRB-
cord-290319-decr6wrd	51	69	0·68	0·68	CD
cord-290319-decr6wrd	51	70	[	[	-LRB-
cord-290319-decr6wrd	51	71	0·51	0·51	CD
cord-290319-decr6wrd	51	72	-	-	SYM
cord-290319-decr6wrd	51	73	0·89	0·89	CD
cord-290319-decr6wrd	51	74	]	]	-RRB-
cord-290319-decr6wrd	51	75	)	)	-RRB-
cord-290319-decr6wrd	51	76	,	,	,
cord-290319-decr6wrd	51	77	which	which	WDT
cord-290319-decr6wrd	51	78	provides	provide	VBZ
cord-290319-decr6wrd	51	79	strong	strong	JJ
cord-290319-decr6wrd	51	80	evidence	evidence	NN
cord-290319-decr6wrd	51	81	of	of	IN
cord-290319-decr6wrd	51	82	both	both	DT
cord-290319-decr6wrd	51	83	cross	cross	NN
cord-290319-decr6wrd	51	84	-	-	NN
cord-290319-decr6wrd	51	85	protection	protection	NN
cord-290319-decr6wrd	51	86	and	and	CC
cord-290319-decr6wrd	51	87	herd	herd	NN
cord-290319-decr6wrd	51	88	eff	eff	NNP
cord-290319-decr6wrd	51	89	ects	ect	NNS
cord-290319-decr6wrd	51	90	.	.	.
cord-290319-decr6wrd	52	1	Smaller	small	JJR
cord-290319-decr6wrd	52	2	,	,	,
cord-290319-decr6wrd	52	3	but	but	CC
cord-290319-decr6wrd	52	4	still	still	RB
cord-290319-decr6wrd	52	5	signifi	signifi	NNP
cord-290319-decr6wrd	52	6	ca	can	MD
cord-290319-decr6wrd	52	7	nt	not	RB
cord-290319-decr6wrd	52	8	,	,	,
cord-290319-decr6wrd	52	9	reductions	reduction	NNS
cord-290319-decr6wrd	52	10	in	in	IN
cord-290319-decr6wrd	52	11	HPV	hpv	NN
cord-290319-decr6wrd	52	12	types	type	NNS
cord-290319-decr6wrd	52	13	16	16	CD
cord-290319-decr6wrd	52	14	and	and	CC
cord-290319-decr6wrd	52	15	18	18	CD
cord-290319-decr6wrd	52	16	infection	infection	NN
cord-290319-decr6wrd	52	17	(	(	-LRB-
cord-290319-decr6wrd	52	18	RR	rr	NN
cord-290319-decr6wrd	52	19	0·50	0·50	CD
cord-290319-decr6wrd	52	20	[	[	-LRB-
cord-290319-decr6wrd	52	21	95	95	CD
cord-290319-decr6wrd	52	22	%	%	NN
cord-290319-decr6wrd	52	23	CI	CI	NNP
cord-290319-decr6wrd	52	24	0·34	0·34	CD
cord-290319-decr6wrd	52	25	-	-	:
cord-290319-decr6wrd	52	26	0·74	0·74	CD
cord-290319-decr6wrd	52	27	]	]	-RRB-
cord-290319-decr6wrd	52	28	)	)	-RRB-
cord-290319-decr6wrd	52	29	and	and	CC
cord-290319-decr6wrd	52	30	anogenital	anogenital	JJ
cord-290319-decr6wrd	52	31	warts	wart	NNS
cord-290319-decr6wrd	52	32	(	(	-LRB-
cord-290319-decr6wrd	52	33	0·86	0·86	CD
cord-290319-decr6wrd	52	34	[	[	-LRB-
cord-290319-decr6wrd	52	35	0·79	0·79	CD
cord-290319-decr6wrd	52	36	-	-	HYPH
cord-290319-decr6wrd	52	37	0·94	0·94	CD
cord-290319-decr6wrd	52	38	]	]	-RRB-
cord-290319-decr6wrd	52	39	)	)	-RRB-
cord-290319-decr6wrd	52	40	also	also	RB
cord-290319-decr6wrd	52	41	occurred	occur	VBD
cord-290319-decr6wrd	52	42	in	in	IN
cord-290319-decr6wrd	52	43	girls	girl	NNS
cord-290319-decr6wrd	52	44	and	and	CC
cord-290319-decr6wrd	52	45	young	young	JJ
cord-290319-decr6wrd	52	46	women	woman	NNS
cord-290319-decr6wrd	52	47	in	in	IN
cord-290319-decr6wrd	52	48	countries	country	NNS
cord-290319-decr6wrd	52	49	with	with	IN
cord-290319-decr6wrd	52	50	lower	low	JJR
cord-290319-decr6wrd	52	51	vaccination	vaccination	NN
cord-290319-decr6wrd	52	52	coverage	coverage	NN
cord-290319-decr6wrd	52	53	(	(	-LRB-
cord-290319-decr6wrd	52	54	<	<	XX
cord-290319-decr6wrd	52	55	50	50	CD
cord-290319-decr6wrd	52	56	%	%	NN
cord-290319-decr6wrd	52	57	)	)	-RRB-
cord-290319-decr6wrd	52	58	,	,	,
cord-290319-decr6wrd	52	59	but	but	CC
cord-290319-decr6wrd	52	60	there	there	EX
cord-290319-decr6wrd	52	61	was	be	VBD
cord-290319-decr6wrd	52	62	no	no	DT
cord-290319-decr6wrd	52	63	evidence	evidence	NN
cord-290319-decr6wrd	52	64	to	to	TO
cord-290319-decr6wrd	52	65	suggest	suggest	VB
cord-290319-decr6wrd	52	66	either	either	CC
cord-290319-decr6wrd	52	67	cross	cross	NN
cord-290319-decr6wrd	52	68	-	-	NN
cord-290319-decr6wrd	52	69	protection	protection	NN
cord-290319-decr6wrd	52	70	or	or	CC
cord-290319-decr6wrd	52	71	herd	herd	NN
cord-290319-decr6wrd	52	72	immunity	immunity	NN
cord-290319-decr6wrd	52	73	in	in	IN
cord-290319-decr6wrd	52	74	these	these	DT
cord-290319-decr6wrd	52	75	countries	country	NNS
cord-290319-decr6wrd	52	76	.	.	.
cord-290319-decr6wrd	53	1	Drolet	Drolet	NNP
cord-290319-decr6wrd	53	2	and	and	CC
cord-290319-decr6wrd	53	3	colleagues	colleague	NNS
cord-290319-decr6wrd	53	4	aimed	aim	VBN
cord-290319-decr6wrd	53	5	to	to	TO
cord-290319-decr6wrd	53	6	report	report	VB
cord-290319-decr6wrd	53	7	the	the	DT
cord-290319-decr6wrd	53	8	populationlevel	populationlevel	NNP
cord-290319-decr6wrd	53	9	eff	eff	NNP
cord-290319-decr6wrd	53	10	ect	ect	FW
cord-290319-decr6wrd	53	11	of	of	IN
cord-290319-decr6wrd	53	12	vaccination	vaccination	NN
cord-290319-decr6wrd	53	13	and	and	CC
cord-290319-decr6wrd	53	14	,	,	,
cord-290319-decr6wrd	53	15	although	although	IN
cord-290319-decr6wrd	53	16	the	the	DT
cord-290319-decr6wrd	53	17	results	result	NNS
cord-290319-decr6wrd	53	18	are	be	VBP
cord-290319-decr6wrd	53	19	very	very	RB
cord-290319-decr6wrd	53	20	encouraging	encouraging	JJ
cord-290319-decr6wrd	53	21	,	,	,
cord-290319-decr6wrd	53	22	we	-PRON-	PRP
cord-290319-decr6wrd	53	23	need	need	VBP
cord-290319-decr6wrd	53	24	to	to	TO
cord-290319-decr6wrd	53	25	keep	keep	VB
cord-290319-decr6wrd	53	26	in	in	IN
cord-290319-decr6wrd	53	27	mind	mind	NN
cord-290319-decr6wrd	53	28	that	that	IN
cord-290319-decr6wrd	53	29	their	-PRON-	PRP$
cord-290319-decr6wrd	53	30	study	study	NN
cord-290319-decr6wrd	53	31	included	include	VBD
cord-290319-decr6wrd	53	32	both	both	DT
cord-290319-decr6wrd	53	33	clinic	clinic	NN
cord-290319-decr6wrd	53	34	-	-	HYPH
cord-290319-decr6wrd	53	35	based	base	VBN
cord-290319-decr6wrd	53	36	and	and	CC
cord-290319-decr6wrd	53	37	population	population	NN
cord-290319-decr6wrd	53	38	-	-	HYPH
cord-290319-decr6wrd	53	39	based	base	VBN
cord-290319-decr6wrd	53	40	studies	study	NNS
cord-290319-decr6wrd	53	41	,	,	,
cord-290319-decr6wrd	53	42	of	of	IN
cord-290319-decr6wrd	53	43	which	which	WDT
cord-290319-decr6wrd	53	44	the	the	DT
cord-290319-decr6wrd	53	45	clinic	clinic	NN
cord-290319-decr6wrd	53	46	-	-	HYPH
cord-290319-decr6wrd	53	47	based	base	VBN
cord-290319-decr6wrd	53	48	studies	study	NNS
cord-290319-decr6wrd	53	49	might	may	MD
cord-290319-decr6wrd	53	50	not	not	RB
cord-290319-decr6wrd	53	51	be	be	VB
cord-290319-decr6wrd	53	52	representative	representative	JJ
cord-290319-decr6wrd	53	53	of	of	IN
cord-290319-decr6wrd	53	54	the	the	DT
cord-290319-decr6wrd	53	55	underlying	underlie	VBG
cord-290319-decr6wrd	53	56	population	population	NN
cord-290319-decr6wrd	53	57	.	.	.
cord-290319-decr6wrd	54	1	Additionally	additionally	RB
cord-290319-decr6wrd	54	2	,	,	,
cord-290319-decr6wrd	54	3	vaccine	vaccine	NN
cord-290319-decr6wrd	54	4	coverage	coverage	NN
cord-290319-decr6wrd	54	5	for	for	IN
cord-290319-decr6wrd	54	6	the	the	DT
cord-290319-decr6wrd	54	7	outcome	outcome	NN
cord-290319-decr6wrd	54	8	of	of	IN
cord-290319-decr6wrd	54	9	HPV	HPV	NNP
cord-290319-decr6wrd	54	10	prevalence	prevalence	NN
cord-290319-decr6wrd	54	11	was	be	VBD
cord-290319-decr6wrd	54	12	based	base	VBN
cord-290319-decr6wrd	54	13	on	on	IN
cord-290319-decr6wrd	54	14	vaccine	vaccine	NN
cord-290319-decr6wrd	54	15	uptake	uptake	NN
cord-290319-decr6wrd	54	16	in	in	IN
cord-290319-decr6wrd	54	17	the	the	DT
cord-290319-decr6wrd	54	18	study	study	NN
cord-290319-decr6wrd	54	19	,	,	,
cord-290319-decr6wrd	54	20	which	which	WDT
cord-290319-decr6wrd	54	21	in	in	IN
cord-290319-decr6wrd	54	22	some	some	DT
cord-290319-decr6wrd	54	23	cases	case	NNS
cord-290319-decr6wrd	54	24	was	be	VBD
cord-290319-decr6wrd	54	25	substantially	substantially	RB
cord-290319-decr6wrd	54	26	larger	large	JJR
cord-290319-decr6wrd	54	27	than	than	IN
cord-290319-decr6wrd	54	28	that	that	DT
cord-290319-decr6wrd	54	29	in	in	IN
cord-290319-decr6wrd	54	30	the	the	DT
cord-290319-decr6wrd	54	31	underlying	underlie	VBG
cord-290319-decr6wrd	54	32	population	population	NN
cord-290319-decr6wrd	54	33	.	.	.
cord-290319-decr6wrd	55	1	8	8	CD
cord-290319-decr6wrd	56	1	Although	although	IN
cord-290319-decr6wrd	56	2	the	the	DT
cord-290319-decr6wrd	56	3	authors	author	NNS
cord-290319-decr6wrd	56	4	did	do	VBD
cord-290319-decr6wrd	56	5	several	several	JJ
cord-290319-decr6wrd	56	6	subanalyses	subanalyse	NNS
cord-290319-decr6wrd	56	7	to	to	TO
cord-290319-decr6wrd	56	8	investigate	investigate	VB
cord-290319-decr6wrd	56	9	heterogeneity	heterogeneity	NN
cord-290319-decr6wrd	56	10	,	,	,
cord-290319-decr6wrd	56	11	we	-PRON-	PRP
cord-290319-decr6wrd	56	12	think	think	VBP
cord-290319-decr6wrd	56	13	it	-PRON-	PRP
cord-290319-decr6wrd	56	14	would	would	MD
cord-290319-decr6wrd	56	15	have	have	VB
cord-290319-decr6wrd	56	16	been	be	VBN
cord-290319-decr6wrd	56	17	helpful	helpful	JJ
cord-290319-decr6wrd	56	18	to	to	TO
cord-290319-decr6wrd	56	19	do	do	VB
cord-290319-decr6wrd	56	20	an	an	DT
cord-290319-decr6wrd	56	21	additional	additional	JJ
cord-290319-decr6wrd	56	22	subanalysis	subanalysis	NN
cord-290319-decr6wrd	56	23	stratifying	stratify	VBG
cord-290319-decr6wrd	56	24	the	the	DT
cord-290319-decr6wrd	56	25	data	datum	NNS
cord-290319-decr6wrd	56	26	by	by	IN
cord-290319-decr6wrd	56	27	clinic	clinic	NN
cord-290319-decr6wrd	56	28	-	-	HYPH
cord-290319-decr6wrd	56	29	based	base	VBN
cord-290319-decr6wrd	56	30	versus	versus	IN
cord-290319-decr6wrd	56	31	population	population	NN
cord-290319-decr6wrd	56	32	-	-	HYPH
cord-290319-decr6wrd	56	33	based	base	VBN
cord-290319-decr6wrd	56	34	study	study	NN
cord-290319-decr6wrd	56	35	.	.	.
cord-290319-decr6wrd	57	1	Disappointingly	disappointingly	RB
cord-290319-decr6wrd	57	2	,	,	,
cord-290319-decr6wrd	57	3	all	all	PDT
cord-290319-decr6wrd	57	4	the	the	DT
cord-290319-decr6wrd	57	5	included	include	VBN
cord-290319-decr6wrd	57	6	studies	study	NNS
cord-290319-decr6wrd	57	7	were	be	VBD
cord-290319-decr6wrd	57	8	from	from	IN
cord-290319-decr6wrd	57	9	high	high	JJ
cord-290319-decr6wrd	57	10	-	-	HYPH
cord-290319-decr6wrd	57	11	income	income	NN
cord-290319-decr6wrd	57	12	countries	country	NNS
cord-290319-decr6wrd	57	13	(	(	-LRB-
cord-290319-decr6wrd	57	14	nine	nine	CD
cord-290319-decr6wrd	57	15	countries	country	NNS
cord-290319-decr6wrd	57	16	in	in	IN
cord-290319-decr6wrd	57	17	total	total	NN
cord-290319-decr6wrd	57	18	)	)	-RRB-
cord-290319-decr6wrd	57	19	and	and	CC
cord-290319-decr6wrd	57	20	we	-PRON-	PRP
cord-290319-decr6wrd	57	21	are	be	VBP
cord-290319-decr6wrd	57	22	therefore	therefore	RB
cord-290319-decr6wrd	57	23	none	none	NN
cord-290319-decr6wrd	57	24	the	the	DT
cord-290319-decr6wrd	57	25	wiser	wise	JJR
cord-290319-decr6wrd	57	26	regarding	regard	VBG
cord-290319-decr6wrd	57	27	the	the	DT
cord-290319-decr6wrd	57	28	eff	eff	NN
cord-290319-decr6wrd	57	29	ect	ect	NN
cord-290319-decr6wrd	57	30	of	of	IN
cord-290319-decr6wrd	57	31	vaccination	vaccination	NN
cord-290319-decr6wrd	57	32	in	in	IN
cord-290319-decr6wrd	57	33	low	low	JJ
cord-290319-decr6wrd	57	34	-	-	HYPH
cord-290319-decr6wrd	57	35	income	income	NN
cord-290319-decr6wrd	57	36	countries	country	NNS
cord-290319-decr6wrd	57	37	in	in	IN
cord-290319-decr6wrd	57	38	which	which	WDT
cord-290319-decr6wrd	57	39	the	the	DT
cord-290319-decr6wrd	57	40	burden	burden	NN
cord-290319-decr6wrd	57	41	of	of	IN
cord-290319-decr6wrd	57	42	HPV	hpv	NN
cord-290319-decr6wrd	57	43	-	-	HYPH
cord-290319-decr6wrd	57	44	associated	associate	VBN
cord-290319-decr6wrd	57	45	disease	disease	NN
cord-290319-decr6wrd	57	46	is	be	VBZ
cord-290319-decr6wrd	57	47	highest	high	JJS
cord-290319-decr6wrd	57	48	.	.	.
cord-290319-decr6wrd	58	1	This	this	DT
cord-290319-decr6wrd	58	2	report	report	NN
cord-290319-decr6wrd	58	3	shows	show	VBZ
cord-290319-decr6wrd	58	4	that	that	IN
cord-290319-decr6wrd	58	5	the	the	DT
cord-290319-decr6wrd	58	6	maximum	maximum	JJ
cord-290319-decr6wrd	58	7	population	population	NN
cord-290319-decr6wrd	58	8	-	-	HYPH
cord-290319-decr6wrd	58	9	level	level	NN
cord-290319-decr6wrd	58	10	eff	eff	NN
cord-290319-decr6wrd	58	11	ect	ect	FW
cord-290319-decr6wrd	58	12	of	of	IN
cord-290319-decr6wrd	58	13	vaccination	vaccination	NN
cord-290319-decr6wrd	58	14	is	be	VBZ
cord-290319-decr6wrd	58	15	achieved	achieve	VBN
cord-290319-decr6wrd	58	16	through	through	IN
cord-290319-decr6wrd	58	17	delivery	delivery	NN
cord-290319-decr6wrd	58	18	at	at	IN
cord-290319-decr6wrd	58	19	a	a	DT
cord-290319-decr6wrd	58	20	young	young	JJ
cord-290319-decr6wrd	58	21	age	age	NN
cord-290319-decr6wrd	58	22	with	with	IN
cord-290319-decr6wrd	58	23	high	high	JJ
cord-290319-decr6wrd	58	24	vaccination	vaccination	NN
cord-290319-decr6wrd	58	25	uptake	uptake	NN
cord-290319-decr6wrd	58	26	rate	rate	NN
cord-290319-decr6wrd	58	27	.	.	.
cord-290319-decr6wrd	59	1	A	a	DT
cord-290319-decr6wrd	59	2	result	result	NN
cord-290319-decr6wrd	59	3	we	-PRON-	PRP
cord-290319-decr6wrd	59	4	found	find	VBD
cord-290319-decr6wrd	59	5	striking	strike	VBG
cord-290319-decr6wrd	59	6	is	be	VBZ
cord-290319-decr6wrd	59	7	that	that	IN
cord-290319-decr6wrd	59	8	the	the	DT
cord-290319-decr6wrd	59	9	greatest	great	JJS
cord-290319-decr6wrd	59	10	eff	eff	NN
cord-290319-decr6wrd	59	11	ect	ect	NN
cord-290319-decr6wrd	59	12	of	of	IN
cord-290319-decr6wrd	59	13	vaccination	vaccination	NN
cord-290319-decr6wrd	59	14	,	,	,
cord-290319-decr6wrd	59	15	in	in	IN
cord-290319-decr6wrd	59	16	both	both	DT
cord-290319-decr6wrd	59	17	male	male	JJ
cord-290319-decr6wrd	59	18	and	and	CC
cord-290319-decr6wrd	59	19	female	female	JJ
cord-290319-decr6wrd	59	20	individuals	individual	NNS
cord-290319-decr6wrd	59	21	,	,	,
cord-290319-decr6wrd	59	22	was	be	VBD
cord-290319-decr6wrd	59	23	recorded	record	VBN
cord-290319-decr6wrd	59	24	for	for	IN
cord-290319-decr6wrd	59	25	countries	country	NNS
cord-290319-decr6wrd	59	26	such	such	JJ
cord-290319-decr6wrd	59	27	as	as	IN
cord-290319-decr6wrd	59	28	Australia	Australia	NNP
cord-290319-decr6wrd	59	29	,	,	,
cord-290319-decr6wrd	59	30	New	New	NNP
cord-290319-decr6wrd	59	31	Zealand	Zealand	NNP
cord-290319-decr6wrd	59	32	,	,	,
cord-290319-decr6wrd	59	33	and	and	CC
cord-290319-decr6wrd	59	34	the	the	DT
cord-290319-decr6wrd	59	35	UK	UK	NNP
cord-290319-decr6wrd	59	36	that	that	WDT
cord-290319-decr6wrd	59	37	have	have	VBP
cord-290319-decr6wrd	59	38	school	school	NN
cord-290319-decr6wrd	59	39	-	-	HYPH
cord-290319-decr6wrd	59	40	based	base	VBN
cord-290319-decr6wrd	59	41	vaccination	vaccination	NN
cord-290319-decr6wrd	59	42	programmes	programme	NNS
cord-290319-decr6wrd	59	43	.	.	.
cord-290319-decr6wrd	60	1	This	this	DT
cord-290319-decr6wrd	60	2	fi	fi	NN
cord-290319-decr6wrd	60	3	nding	nding	NN
cord-290319-decr6wrd	60	4	is	be	VBZ
cord-290319-decr6wrd	60	5	corroborated	corroborate	VBN
cord-290319-decr6wrd	60	6	by	by	IN
cord-290319-decr6wrd	60	7	the	the	DT
cord-290319-decr6wrd	60	8	results	result	NNS
cord-290319-decr6wrd	60	9	of	of	IN
cord-290319-decr6wrd	60	10	another	another	DT
cord-290319-decr6wrd	60	11	recent	recent	JJ
cord-290319-decr6wrd	60	12	systematic	systematic	JJ
cord-290319-decr6wrd	60	13	review	review	NN
cord-290319-decr6wrd	60	14	that	that	WDT
cord-290319-decr6wrd	60	15	assessed	assess	VBD
cord-290319-decr6wrd	60	16	the	the	DT
cord-290319-decr6wrd	60	17	eff	eff	NN
cord-290319-decr6wrd	60	18	ect	ect	NN
cord-290319-decr6wrd	60	19	of	of	IN
cord-290319-decr6wrd	60	20	the	the	DT
cord-290319-decr6wrd	60	21	quadrivalent	quadrivalent	NN
cord-290319-decr6wrd	60	22	vaccine	vaccine	NN
cord-290319-decr6wrd	60	23	on	on	IN
cord-290319-decr6wrd	60	24	anogenital	anogenital	JJ
cord-290319-decr6wrd	60	25	warts	wart	NNS
cord-290319-decr6wrd	60	26	.	.	.
cord-290319-decr6wrd	61	1	9	9	CD
cord-290319-decr6wrd	62	1	In	in	IN
cord-290319-decr6wrd	62	2	this	this	DT
cord-290319-decr6wrd	62	3	study	study	NN
cord-290319-decr6wrd	62	4	,	,	,
cord-290319-decr6wrd	62	5	Mariani	Mariani	NNP
cord-290319-decr6wrd	62	6	and	and	CC
cord-290319-decr6wrd	62	7	colleagues	colleague	NNS
cord-290319-decr6wrd	62	8	reported	report	VBD
cord-290319-decr6wrd	62	9	that	that	IN
cord-290319-decr6wrd	62	10	the	the	DT
cord-290319-decr6wrd	62	11	greatest	great	JJS
cord-290319-decr6wrd	62	12	reductions	reduction	NNS
cord-290319-decr6wrd	62	13	in	in	IN
cord-290319-decr6wrd	62	14	anogenital	anogenital	JJ
cord-290319-decr6wrd	62	15	warts	wart	NNS
cord-290319-decr6wrd	62	16	were	be	VBD
cord-290319-decr6wrd	62	17	achieved	achieve	VBN
cord-290319-decr6wrd	62	18	in	in	IN
cord-290319-decr6wrd	62	19	countries	country	NNS
cord-290319-decr6wrd	62	20	with	with	IN
cord-290319-decr6wrd	62	21	high	high	JJ
cord-290319-decr6wrd	62	22	vaccination	vaccination	NN
cord-290319-decr6wrd	62	23	uptake	uptake	NN
cord-290319-decr6wrd	62	24	rates	rate	NNS
cord-290319-decr6wrd	62	25	,	,	,
cord-290319-decr6wrd	62	26	mostly	mostly	RB
cord-290319-decr6wrd	62	27	through	through	IN
cord-290319-decr6wrd	62	28	school	school	NN
cord-290319-decr6wrd	62	29	-	-	HYPH
cord-290319-decr6wrd	62	30	based	base	VBN
cord-290319-decr6wrd	62	31	vaccination	vaccination	NN
cord-290319-decr6wrd	62	32	programmes	programme	NNS
cord-290319-decr6wrd	62	33	,	,	,
cord-290319-decr6wrd	62	34	although	although	IN
cord-290319-decr6wrd	62	35	some	some	DT
cord-290319-decr6wrd	62	36	non	non	JJ
cord-290319-decr6wrd	62	37	-	-	JJ
cord-290319-decr6wrd	62	38	school	school	NN
cord-290319-decr6wrd	62	39	-	-	HYPH
cord-290319-decr6wrd	62	40	based	base	VBN
cord-290319-decr6wrd	62	41	programmes	programme	NNS
cord-290319-decr6wrd	62	42	also	also	RB
cord-290319-decr6wrd	62	43	achieved	achieve	VBD
cord-290319-decr6wrd	62	44	high	high	JJ
cord-290319-decr6wrd	62	45	vaccination	vaccination	NN
cord-290319-decr6wrd	62	46	uptake	uptake	NN
cord-290319-decr6wrd	62	47	rates	rate	NNS
cord-290319-decr6wrd	62	48	.	.	.
cord-290319-decr6wrd	63	1	One	one	CD
cord-290319-decr6wrd	63	2	concern	concern	NN
cord-290319-decr6wrd	63	3	with	with	IN
cord-290319-decr6wrd	63	4	school	school	NN
cord-290319-decr6wrd	63	5	-	-	HYPH
cord-290319-decr6wrd	63	6	based	base	VBN
cord-290319-decr6wrd	63	7	programmes	programme	NNS
cord-290319-decr6wrd	63	8	is	be	VBZ
cord-290319-decr6wrd	63	9	the	the	DT
cord-290319-decr6wrd	63	10	Presence	Presence	NNP
cord-290319-decr6wrd	63	11	of	of	IN
cord-290319-decr6wrd	63	12	Middle	Middle	NNP
cord-290319-decr6wrd	63	13	East	East	NNP
cord-290319-decr6wrd	63	14	respiratory	respiratory	JJ
cord-290319-decr6wrd	63	15	syndrome	syndrome	NN
cord-290319-decr6wrd	63	16	coronavirus	coronavirus	NN
cord-290319-decr6wrd	63	17	antibodies	antibody	NNS
cord-290319-decr6wrd	63	18	in	in	IN
cord-290319-decr6wrd	63	19	Saudi	Saudi	NNP
cord-290319-decr6wrd	63	20	Arabia	Arabia	NNP
cord-290319-decr6wrd	63	21	:	:	:
cord-290319-decr6wrd	63	22	a	a	DT
cord-290319-decr6wrd	63	23	nationwide	nationwide	JJ
cord-290319-decr6wrd	63	24	,	,	,
cord-290319-decr6wrd	63	25	crosssectional	crosssectional	JJ
cord-290319-decr6wrd	63	26	serological	serological	JJ
cord-290319-decr6wrd	63	27	study	study	NN
cord-290319-decr6wrd	63	28	Isolation	isolation	NN
cord-290319-decr6wrd	63	29	of	of	IN
cord-290319-decr6wrd	63	30	a	a	DT
cord-290319-decr6wrd	63	31	novel	novel	JJ
cord-290319-decr6wrd	63	32	coronavirus	coronavirus	NN
cord-290319-decr6wrd	63	33	from	from	IN
cord-290319-decr6wrd	63	34	a	a	DT
cord-290319-decr6wrd	63	35	man	man	NN
cord-290319-decr6wrd	63	36	with	with	IN
cord-290319-decr6wrd	63	37	pneumonia	pneumonia	NN
cord-290319-decr6wrd	63	38	in	in	IN
cord-290319-decr6wrd	63	39	Saudi	Saudi	NNP
cord-290319-decr6wrd	63	40	Arabia	Arabia	NNP
cord-290319-decr6wrd	63	41	MERS	MERS	NNP
cord-290319-decr6wrd	63	42	-	-	HYPH
cord-290319-decr6wrd	63	43	CoV	CoV	NNP
cord-290319-decr6wrd	63	44	)	)	-RRB-
cord-290319-decr6wrd	64	1	:	:	:
cord-290319-decr6wrd	64	2	summary	summary	NN
cord-290319-decr6wrd	64	3	of	of	IN
cord-290319-decr6wrd	64	4	current	current	JJ
cord-290319-decr6wrd	64	5	situation	situation	NN
cord-290319-decr6wrd	64	6	,	,	,
cord-290319-decr6wrd	64	7	literature	literature	NN
cord-290319-decr6wrd	64	8	update	update	NN
cord-290319-decr6wrd	64	9	and	and	CC
cord-290319-decr6wrd	64	10	risk	risk	NN
cord-290319-decr6wrd	64	11	assessment	assessment	NN
cord-290319-decr6wrd	64	12	Human	Human	NNP
cord-290319-decr6wrd	64	13	betacoronavirus	betacoronavirus	NN
cord-290319-decr6wrd	64	14	2c	2c	NNS
cord-290319-decr6wrd	64	15	EMC/2012-related	emc/2012-relate	VBD
cord-290319-decr6wrd	64	16	viruses	virus	NNS
cord-290319-decr6wrd	64	17	in	in	IN
cord-290319-decr6wrd	64	18	bats	bat	NNS
cord-290319-decr6wrd	64	19	,	,	,
cord-290319-decr6wrd	64	20	Ghana	Ghana	NNP
cord-290319-decr6wrd	64	21	and	and	CC
cord-290319-decr6wrd	64	22	Europe	Europe	NNP
cord-290319-decr6wrd	64	23	Close	Close	NNP
cord-290319-decr6wrd	64	24	relative	relative	NN
cord-290319-decr6wrd	64	25	of	of	IN
cord-290319-decr6wrd	64	26	human	human	JJ
cord-290319-decr6wrd	64	27	Middle	Middle	NNP
cord-290319-decr6wrd	64	28	East	East	NNP
cord-290319-decr6wrd	64	29	respiratory	respiratory	JJ
cord-290319-decr6wrd	64	30	syndrome	syndrome	NN
cord-290319-decr6wrd	64	31	coronavirus	coronavirus	NN
cord-290319-decr6wrd	64	32	in	in	IN
cord-290319-decr6wrd	64	33	bat	bat	NN
cord-290319-decr6wrd	64	34	MERS	MERS	NNP
cord-290319-decr6wrd	64	35	-	-	HYPH
cord-290319-decr6wrd	64	36	Related	relate	VBN
cord-290319-decr6wrd	64	37	Betacoronavirus	Betacoronavirus	NNP
cord-290319-decr6wrd	64	38	in	in	IN
cord-290319-decr6wrd	64	39	Vespertilio	Vespertilio	NNP
cord-290319-decr6wrd	65	1	Superans	superan	NNS
cord-290319-decr6wrd	65	2	bats	bat	NNS
cord-290319-decr6wrd	66	1	Middle	Middle	NNP
cord-290319-decr6wrd	66	2	East	East	NNP
cord-290319-decr6wrd	66	3	respiratory	respiratory	JJ
cord-290319-decr6wrd	66	4	syndrome	syndrome	NN
cord-290319-decr6wrd	66	5	:	:	:
cord-290319-decr6wrd	67	1	An	an	DT
cord-290319-decr6wrd	67	2	emerging	emerge	VBG
cord-290319-decr6wrd	67	3	coronavirus	coronavirus	NN
cord-290319-decr6wrd	67	4	infection	infection	NN
cord-290319-decr6wrd	67	5	tracked	track	VBN
cord-290319-decr6wrd	67	6	by	by	IN
cord-290319-decr6wrd	67	7	the	the	DT
cord-290319-decr6wrd	67	8	crowd	crowd	NN
cord-290319-decr6wrd	67	9	MERS	MERS	NNP
cord-290319-decr6wrd	67	10	coronaviruses	coronaviruse	NNS
cord-290319-decr6wrd	67	11	in	in	IN
cord-290319-decr6wrd	67	12	dromedary	dromedary	NN
cord-290319-decr6wrd	67	13	camels	camel	NNS
cord-290319-decr6wrd	67	14	MERS	MERS	NNP
cord-290319-decr6wrd	67	15	coronavirus	coronavirus	NN
cord-290319-decr6wrd	67	16	in	in	IN
cord-290319-decr6wrd	67	17	dromedary	dromedary	NN
cord-290319-decr6wrd	67	18	camel	camel	NN
cord-290319-decr6wrd	67	19	herd	herd	NN
cord-290319-decr6wrd	67	20	,	,	,
cord-290319-decr6wrd	67	21	Saudi	Saudi	NNP
cord-290319-decr6wrd	67	22	Arabia	Arabia	NNP
cord-290319-decr6wrd	67	23	Middle	Middle	NNP
cord-290319-decr6wrd	67	24	East	East	NNP
cord-290319-decr6wrd	67	25	respiratory	respiratory	JJ
cord-290319-decr6wrd	67	26	syndrome	syndrome	NN
cord-290319-decr6wrd	67	27	coronavirus	coronavirus	NN
cord-290319-decr6wrd	67	28	in	in	IN
cord-290319-decr6wrd	67	29	dromedary	dromedary	NN
cord-290319-decr6wrd	67	30	camels	camel	NNS
cord-290319-decr6wrd	67	31	:	:	:
cord-290319-decr6wrd	67	32	an	an	DT
cord-290319-decr6wrd	67	33	outbreak	outbreak	NN
cord-290319-decr6wrd	67	34	investigation	investigation	NN
cord-290319-decr6wrd	67	35	Human	human	JJ
cord-290319-decr6wrd	67	36	infection	infection	NN
cord-290319-decr6wrd	67	37	with	with	IN
cord-290319-decr6wrd	67	38	MERS	MERS	NNP
cord-290319-decr6wrd	67	39	coronavirus	coronavirus	NN
cord-290319-decr6wrd	67	40	after	after	IN
cord-290319-decr6wrd	67	41	exposure	exposure	NN
cord-290319-decr6wrd	67	42	to	to	IN
cord-290319-decr6wrd	67	43	infected	infected	JJ
cord-290319-decr6wrd	67	44	camels	camel	NNS
cord-290319-decr6wrd	67	45	,	,	,
cord-290319-decr6wrd	67	46	Saudi	Saudi	NNP
cord-290319-decr6wrd	67	47	Arabia	Arabia	NNP
cord-290319-decr6wrd	67	48	Investigation	Investigation	NNP
cord-290319-decr6wrd	67	49	of	of	IN
cord-290319-decr6wrd	67	50	anti	anti	JJ
cord-290319-decr6wrd	67	51	-	-	JJ
cord-290319-decr6wrd	67	52	middle	middle	JJ
cord-290319-decr6wrd	67	53	East	East	NNP
cord-290319-decr6wrd	67	54	respiratory	respiratory	JJ
cord-290319-decr6wrd	67	55	syndrome	syndrome	NN
cord-290319-decr6wrd	67	56	antibodies	antibody	NNS
cord-290319-decr6wrd	67	57	in	in	IN
cord-290319-decr6wrd	67	58	blood	blood	NN
cord-290319-decr6wrd	67	59	donors	donor	NNS
cord-290319-decr6wrd	67	60	and	and	CC
cord-290319-decr6wrd	67	61	slaughterhouse	slaughterhouse	NN
cord-290319-decr6wrd	67	62	workers	worker	NNS
cord-290319-decr6wrd	67	63	in	in	IN
cord-290319-decr6wrd	67	64	Jeddah	Jeddah	NNP
cord-290319-decr6wrd	67	65	and	and	CC
cord-290319-decr6wrd	67	66	Makkah	Makkah	NNP
cord-290319-decr6wrd	67	67	,	,	,
cord-290319-decr6wrd	67	68	Saudi	Saudi	NNP
cord-290319-decr6wrd	67	69	Arabia	Arabia	NNP
cord-290319-decr6wrd	67	70	,	,	,
cord-290319-decr6wrd	67	71	fall	fall	VB
cord-290319-decr6wrd	67	72	2012	2012	CD
cord-290319-decr6wrd	67	73	Sparse	sparse	JJ
cord-290319-decr6wrd	67	74	evidence	evidence	NN
cord-290319-decr6wrd	67	75	of	of	IN
cord-290319-decr6wrd	67	76	MERS	MERS	NNP
cord-290319-decr6wrd	67	77	-	-	HYPH
cord-290319-decr6wrd	67	78	CoV	cov	NN
cord-290319-decr6wrd	67	79	infection	infection	NN
cord-290319-decr6wrd	67	80	among	among	IN
cord-290319-decr6wrd	67	81	animal	animal	NN
cord-290319-decr6wrd	67	82	workers	worker	NNS
cord-290319-decr6wrd	67	83	living	live	VBG
cord-290319-decr6wrd	67	84	in	in	IN
cord-290319-decr6wrd	67	85	Southern	Southern	NNP
cord-290319-decr6wrd	67	86	Saudi	Saudi	NNP
cord-290319-decr6wrd	67	87	Arabia	Arabia	NNP
cord-290319-decr6wrd	67	88	during	during	IN
cord-290319-decr6wrd	67	89	2012	2012	CD
cord-290319-decr6wrd	67	90	Lack	lack	NN
cord-290319-decr6wrd	67	91	of	of	IN
cord-290319-decr6wrd	67	92	Middle	Middle	NNP
cord-290319-decr6wrd	67	93	East	East	NNP
cord-290319-decr6wrd	67	94	respiratory	respiratory	JJ
cord-290319-decr6wrd	67	95	syndrome	syndrome	NN
cord-290319-decr6wrd	67	96	coronavirus	coronavirus	NN
cord-290319-decr6wrd	67	97	transmission	transmission	NN
cord-290319-decr6wrd	67	98	from	from	IN
cord-290319-decr6wrd	67	99	infected	infected	JJ
cord-290319-decr6wrd	67	100	camels	camel	NNS
cord-290319-decr6wrd	67	101	Acute	Acute	NNP
cord-290319-decr6wrd	67	102	Middle	Middle	NNP
cord-290319-decr6wrd	67	103	East	East	NNP
cord-290319-decr6wrd	67	104	respiratory	respiratory	JJ
cord-290319-decr6wrd	67	105	syndrome	syndrome	NN
cord-290319-decr6wrd	67	106	coronavirus	coronavirus	NN
cord-290319-decr6wrd	67	107	infection	infection	NN
cord-290319-decr6wrd	67	108	in	in	IN
cord-290319-decr6wrd	67	109	livestock	livestock	NN
cord-290319-decr6wrd	67	110	dromedaries	dromedary	NNS